Malignant neoplasm of endocrine gland, including Hilmo

C3_ENDOCRINE_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_THYROID_GLAND_WIDE C3_ADRENAL_GLAND_WIDE C3_ENDOCRINE_NAS_WIDE	3842
6. Filter based on genotype QC (FinnGen only)	3489

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF14

NAME	C3_ENDOCRINE_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_THYROID_GLAND_WIDE\|C3_ADRENAL_GLAND_WIDE\|C3_ENDOCRINE_NAS_WIDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of endocrine gland, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3489	2498	991
Unadjusted period prevalence (%)	0.76	0.89	0.45
Median age at first event (years)	53.14	50.52	59.74

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3620: Matched controls
36200

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

307.7

471

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

20.6

307.7

363

195

H02AB02

ATC

dexamethasone; systemic

25.2

307.7

442

199

106

Kela drug reimbursment

Hypoparathyroidism

69.1

307.7

190

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

164.3

307.7

187

BAA60

NOMESCO Finland

Total thyroidectomy

106.6

307.7

1738

311

ZX114

NOMESCO Finland

Intramuscular

41.7

307.7

482

133

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

9.8

307.7

558

660

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

33.6

307.7

485

166

A04AA02

ATC

granisetron; systemic, transdermal

192.4

307.7

234

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

106.4

307.7

220

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

83.2

307.7

241

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

4503599627370496.0

307.7

2456

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.0

307.7

2109

7917

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

307.7

370

H03AA01

ATC

levothyroxine sodium; systemic

28.0

307.7

3086

6198

EP1AE

NOMESCO Finland

Neck ultrasound examination

39.7

307.7

1633

734

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

74.9

307.7

1134

219

A11CC03

ATC

alfacalcidol; systemic

13.9

307.7

341

269

4CJ01, ,

NOMESCO Finland

+∞

307.7

316

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

93.3

307.7

911

130

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

133.7

307.7

882

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

307.7

397

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

307.7

2151

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

307.7

432

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

30.1

307.7

817

347

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

4071.0

307.7

377

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

54.4

307.7

244

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

307.7

717

104

Kela drug reimbursment

Thyroid insufficiency

39.9

307.7

2239

1414

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

527

WF002

NOMESCO Finland

Radical radiotherapy

59.8

306.1

171

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

69.2

292.0

159

115

Kela drug reimbursment

Breast cancer

+∞

285.2

270

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

78.9

269.7

144

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

12.1

263.1

271

240

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

45.9

261.2

154

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

259.6

246

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

255.3

242

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

11.2

250.2

272

261

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

+∞

246.7

234

WX402

NOMESCO Finland

General anaesthesia

3.5

246.7

1177

4405

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

24.1

244.0

175

L02BA01

ATC

tamoxifen; oral

127.3

243.3

123

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

242.5

230

PJA12

NOMESCO Finland

Sentinel node biopsy

490.7

234.0

231

WX408

NOMESCO Finland

General anesthesy, balanced

3.3

229.8

1258

5087

XX3DW

NOMESCO Finland

Time consuming IT work

6.1

219.1

410

744

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

16.8

217.9

184

115

JN4BD

NOMESCO Finland

Extensive body CT

6.4

212.5

375

642

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

8.1

210.3

294

391

T71

ICPC

Malignant neoplasm thyroid

+∞

207.3

197

Z51.88

ICD-10 Finland

Other specified medical care

9.6

200.3

242

268

E83.51

ICD-10 Finland

Hypocalcemia

22.8

198.2

145

WF049

NOMESCO Finland

Radiotherapy of metastasis

681.2

198.1

194

WZC00

NOMESCO Finland

Treatment plan or consultation

2.8

194.4

1588

7872

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

17.3

190.6

158

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.2

188.0

982

3803

A03FA01

ATC

metoclopramide; systemic, rectal

3.4

184.7

832

2945

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

179.7

171

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

33.6

178.4

114

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

177.6

169

ZXE10

NOMESCO Finland

More than one and less than three hours

2.7

175.0

1579

8127

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

23.9

174.3

125

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

7.8

172.3

248

340

2506

FHL

Thyroidectomy

254.7

166.9

170

JN4AD

NOMESCO Finland

Body CT examination

4.8

166.7

408

934

A11CC02

ATC

dihydrotachysterol; oral

38.8

166.2

102

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

5.7

163.6

320

602

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

159.6

152

HAB40

NOMESCO Finland

Wedge excision of mammary gland

18.5

158.5

127

Z51.5

ICD-10 Finland

Palliative care

5.9

152.5

287

520

L02BG04

ATC

letrozole; oral

8.9

149.8

191

226

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

511.9

149.7

148

JN6AD

NOMESCO Finland

CT of torso and neck

20.1

149.2

115

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

147.9

141

L03AA13

ATC

pegfilgrastim; parenteral

742.6

146.1

143

8341/3-C73.9

ICD-O-3

Papillary microcarcinoma of thyroid gland

+∞

145.8

139

ZXE20

NOMESCO Finland

More than three and less than five hours

3.4

145.8

620

2095

C61

ICD-10 Finland

Malignant neoplasm of prostate

497.4

145.5

144

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

141.6

135

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

23.3

140.9

102

A04AA01

ATC

ondansetron; systemic, rectal

5.4

138.8

289

574

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

74.5

135.3

A12AA04

ATC

calcium carbonate; oral

9.9

130.8

152

159

TPH07

NOMESCO Finland

Cathetrisation of artery

3.4

129.1

515

1665

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

272.3

129.0

131

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

126.8

121

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

126.8

121

WZC30

NOMESCO Finland

Teaching

3.0

126.6

677

2601

WF003

NOMESCO Finland

Adjuvant radiotherapy

640.0

126.2

124

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

192.6

125.4

130

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1239.8

123.7

120

HA1AA

NOMESCO Finland

X-ray mammography

4.7

121.2

294

664

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

36.4

120.2

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

119.4

114

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.1

117.3

261

548

8340/3-C73.9

ICD-O-3

Papillary carcinoma, follicular variant of thyroid gland

+∞

115.2

110

HAC20

NOMESCO Finland

Total mastectomy

137.9

112.8

120

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

112.1

107

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.8

112.0

268

598

C739, ,

ICD-10 Finland

+∞

111.0

106

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

53.4

110.3

GD6AD

NOMESCO Finland

CT of chest and neck

32.4

108.4

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

1069.4

106.9

104

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

222.6

105.2

108

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

+∞

103.6

T86

ICPC

Hypothyroidism/myxoedema

3.7

103.0

352

1023

A04AA55

ATC

palonosetron, combinations; systemic

+∞

101.5

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.6

100.7

358

1068

E03.89

ICD-10 Finland

Other specified hypothyroidism

4.0

99.8

306

824

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

33.7

98.7

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

+∞

98.4

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

9.3

95.2

116

129

NK6AN

NOMESCO Finland

Total body bone isotope imaging

30.0

93.8

C50.99

ICD-10 Finland

Breast, unspecified

313.7

90.2

L01BC06

ATC

capecitabine; oral

+∞

90.0

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

89.4

1469

9080

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

889.9

89.1

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

889.9

89.1

C74.1

ICD-10 Finland

Malignant neoplasm: Medulla of adrenal gland

+∞

88.9

ZSB00

NOMESCO Finland

Procedure related to previous procedure classified in chapter B

51.7

88.6

JN4CD

NOMESCO Finland

Very extensive body CT

8.5

87.9

115

140

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

20.1

87.1

L03AA02

ATC

filgrastim; parenteral

134.8

86.4

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

13.0

86.3

116

Kela drug reimbursment

Prostate cancer

+∞

85.8

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

847.9

84.9

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

46.1

84.7

PJD91

NOMESCO Finland

Excision of lymph nodes in neck, 1 to 2 areas in total

837.5

83.9

WF004

NOMESCO Finland

Palliative radiotherapy

837.5

83.9

H02AB09

ATC

hydrocortisone; systemic

5.5

82.7

164

310

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

82.6

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

20.0

81.8

WX302

NOMESCO Finland

Thoracal epidural anesthesy

5.2

81.6

174

351

GD1AD

NOMESCO Finland

Thorax CT examination

3.6

80.8

282

828

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

806.0

80.7

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

28.3

78.6

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

7.2

78.0

117

167

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

10.1

77.4

WX704

NOMESCO Finland

Intubation

2.9

76.5

389

1432

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

28.7

76.0

C73.94

ICD-10 Finland

Medullary thyroid carcinoma (thyroid)

+∞

75.3

E27.5

ICD-10 Finland

Adrenomedullary hyperfunction

380.2

75.0

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

72.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.0

70.7

211

555

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

70.4

1693

11617

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

8.6

70.0

107

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

9.2

70.0

N02AA05

ATC

oxycodone; systemic

2.4

69.6

577

2693

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.1

67.5

190

479

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

5.7

66.2

124

222

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

660.1

66.1

EP1AE, ,

SPAT

4.4

65.8

168

393

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.2

65.4

659

3330

ZX090

NOMESCO Finland

Other technic of radiotherapy

91.9

65.1

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

639.3

64.1

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

26.2

63.5

BCA30

NOMESCO Finland

Unilateral adrenalectomy

115.5

63.0

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

7.8

62.1

112

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

318.3

61.5

Z31.5

ICD-10 Finland

Genetic counselling

3.3

61.5

238

745

ZX070

NOMESCO Finland

Intensity modified radiotherapy

162.8

61.1

WZC15, ,

NOMESCO Finland

26.5

60.9

WW500

NOMESCO Finland

Blood transfusion

5.4

60.3

121

231

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

59.5

WW200

NOMESCO Finland

Immunization

4.4

58.8

152

359

JN5SN, ,

NOMESCO Finland

+∞

58.5

A79

ICPC

Malignancy NOS

577.2

57.8

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

24.4

57.6

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

57.4

ZXA10

NOMESCO Finland

Bilateral

2.0

57.4

731

4018

C50

ICD-10 Finland

Malignant neoplasm of breast

199.9

57.2

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

25.3

56.9

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

56.4

B01AB10

ATC

tinzaparin; parenteral

2.5

54.6

375

1599

B01AB05

ATC

enoxaparin; parenteral

1.8

54.4

1059

6681

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

189.5

54.1

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

53.3

XW000

NOMESCO Finland

Bone marrow biopsy

4.7

53.1

126

278

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.8

52.4

119

253

8290/3-C73.9

ICD-O-3

Oxyphilic adenocarcinoma of thyroid gland

+∞

52.2

C73.93

ICD-10 Finland

Anaplastic thyroid carcinoma (thyroid)

+∞

52.2

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

84.3

52.0

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

4.1

51.7

144

360

PJA10

NOMESCO Finland

Exploration of lymph nodes

11.7

51.6

ZXA05

NOMESCO Finland

Left side

1.9

51.5

851

5087

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

51.2

767

4440

XX1MN

NOMESCO Finland

Isotope examination with measurement

+∞

51.2

A12AA06

ATC

calcium lactate gluconate; oral

73.8

51.1

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.7

50.5

ZX080

NOMESCO Finland

Image guided radiotherapy

259.0

50.2

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

259.0

50.2

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

50.1

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

50.1

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

4.8

49.6

113

241

Y77

ICPC

Malignant neoplasm prostate

494.6

49.5

JN5AN

NOMESCO Finland

Total body isotope imaging

+∞

49.1

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

13.9

47.6

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

473.9

47.4

C75.0

ICD-10 Finland

Malignant neoplasm: Parathyroid gland

473.9

47.4

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

47.0

A04AD12

ATC

aprepitant; systemic

165.5

46.9

ZXE00

NOMESCO Finland

One hour or less

1.7

46.9

1358

9500

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

60.9

46.4

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

45.9

L02AE02

ATC

leuprorelin; implant, parenteral

6.1

45.0

133

L02BG03

ATC

anastrozole; oral

84.6

44.9

BAA99

NOMESCO Finland

Other operation on thyroid gland

158.7

44.9

X76

ICPC

Malignant neoplasm breast female

158.7

44.9

8700/3-C74.1

ICD-O-3

Pheochromocytoma, NOS, of medulla of adrenal gland

+∞

44.9

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

5.6

44.8

154

XX2RW, ,

NOMESCO Finland

7.5

44.1

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

43.8

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

43.8

198

Kela drug reimbursment

Sorafenib

+∞

42.8

8700/3-C74.9

ICD-O-3

Pheochromocytoma, NOS, of adrenal gland, NOS

+∞

42.8

BAA20

NOMESCO Finland

Unilateral partial excision of thyroid gland

12.9

42.6

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

41.7

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

91.2

40.8

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

40.7

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

401.9

40.2

3019

Kela drug reimbursment

Lenvatinib

+∞

39.6

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

9.7

39.5

2504

FHL

Unilateral resection or enucleation

6.9

39.4

N02BE01

ATC

paracetamol; systemic, rectal

2.0

39.4

3223

28925

L02BG06

ATC

exemestane; oral

391.7

39.1

1508

Kela drug reimbursment

Lenvatinib

+∞

38.6

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

38.6

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

38.6

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

7.1

38.6

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

38.3

231

922

KCD02

NOMESCO Finland

Transurethral resection of bladder

13.5

38.2

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

63.6

38.1

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

381.4

38.1

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

11.2

38.0

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

85.0

37.8

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

37.6

8345/3-C73.9

ICD-O-3

Medullary thyroid carcinoma of thyroid gland

+∞

37.6

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

3.1

37.4

157

515

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.7

37.4

212

820

A06AH03

ATC

naloxegol; oral

10.1

37.2

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

371.1

37.1

E03

ICD-10 Finland

Other hypothyroidism

2.3

37.0

294

1331

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

11.6

36.9

BA1AQ

NOMESCO Finland

Thyroid SPECT with low dose CT

192.0

36.8

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.9

36.6

114

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.5

36.5

232

949

8370/3-C74.0

ICD-O-3

Adrenal cortical carcinoma of cortex of adrenal gland

+∞

36.5

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.5

36.0

203

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

81.0

35.9

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

35.5

ZX112

NOMESCO Finland

Subcutaneous

6.5

35.4

L01XX23

ATC

mitotane; oral

+∞

34.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

34.2

432

2335

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.5

34.2

228

954

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

10.1

33.6

8510/3-C73.9

ICD-O-3

Medullary carcinoma, NOS, of thyroid gland

+∞

33.4

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.6

33.2

206

833

ZXA00

NOMESCO Finland

Right side

1.7

33.2

862

5762

S18

ICPC

Laceration/cut

1.5

33.1

1581

12168

TQW20

NOMESCO Finland

Tatoe

64.0

33.0

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

33.0

168

614

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

37.7

32.4

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

32.3

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

32.3

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

32.3

L02BB03

ATC

bicalutamide; oral

+∞

32.3

L01EX08

ATC

lenvatinib; oral

+∞

32.3

D70.82

ICD-10 Finland

Drug-induced neutropenia

10.7

32.2

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.1

31.9

214

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.4

31.8

119

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

166.5

31.7

H03BB01

ATC

carbimazole; oral

2.6

31.7

195

785

ZX120

NOMESCO Finland

Intravenous

2.3

31.6

251

1135

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

7.3

31.4

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

31.3

323

Kela drug reimbursment

Sorafenib

+∞

31.3

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

31.3

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

12.0

30.8

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

46.7

30.6

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

5.7

30.5

102

E8901, C7391,

ICD-10 Finland

+∞

30.2

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

11.6

30.0

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

4.3

29.8

178

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.4

29.2

168

C75.9

ICD-10 Finland

Malignant neoplasm: Endocrine gland, unspecified

+∞

29.2

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

29.2

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

29.2

8020/3-C73.9

ICD-O-3

Carcinoma, undifferentiated, NOS, of thyroid gland

+∞

29.2

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

29.2

ZX050

NOMESCO Finland

Stereotactic radiotherapy

57.2

29.1

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

8.3

29.1

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

29.1

267

1281

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

7.8

28.9

XX9XW, ,

NOMESCO Finland

6.9

28.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

28.5

529

3218

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

6.2

28.3

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

28.2

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

28.1

303

1546

BA1AE, ,

SPAT

4.0

27.9

200

PJD99

NOMESCO Finland

Excision of other lymph nodes

146.1

27.7

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.0

27.6

330

1746

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

27.3

828

5709

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.5

27.2

269

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

27.1

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

26.8

286

1453

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

273.1

26.7

E83.50

ICD-10 Finland

Hypercalcemia

4.3

26.7

159

Z51.0

ICD-10 Finland

Radiotherapy session

97.5

26.7

BA2AT

NOMESCO Finland

Biopsy of thyroid with ultrasound quidance

29.4

26.3

BBA20

NOMESCO Finland

Exploration of parathyroid gland

9.5

26.2

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

26.1

8000/3-C73.9

ICD-O-3

Neoplasm, malignant of thyroid gland

+∞

26.1

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

26.1

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

26.1

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

26.1

E21.0

ICD-10 Finland

Primary hyperparathyroidism

3.2

25.7

101

319

128

Kela drug reimbursment

Cancers of female genital organs

136.0

25.6

ZXC96

NOMESCO Finland

Robot assisted procedure

6.2

25.3

R4110

NOMESCO Finland

Physiotherapy

1.5

25.3

863

6094

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

8.0

25.1

SPAT1153

SPAT

Removal of sutures

1.5

25.1

978

7107

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

8.9

25.1

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

25.0

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

25.0

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

58.4

25.0

BWD00

NOMESCO Finland

Reoperation for deep haemorrhage in endocrine surgery

43.2

24.6

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

48.7

24.3

ZZR00

NOMESCO Finland

Flap of skin

7.1

24.2

24199

ICD-8 Finland

Non-toxic nodular goitre, Unspecified

4.9

24.1

110

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

24.0

1930X

ICD-9 Finland

Malignant neoplasm of thyroid gland[NEOPLASMA MALIGNUM THYREOIDEAE EI HISTOL VAHV]

+∞

24.0

C90.0

ICD-10 Finland

Multiple myeloma

+∞

24.0

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

24.0

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

24.0

8010/3-C75.0

ICD-O-3

Carcinoma, NOS, of parathyroid gland

+∞

24.0

Z3226

NOMESCO Finland

Physiotherapist

1.6

23.8

577

3757

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

23.7

287

1523

L01XX05

ATC

hydroxycarbamide; oral

31.3

23.7

JDB10

NOMESCO Finland

Percutaneous gastrostomy

6.3

23.5

UJC01

NOMESCO Finland

Scopy of lower throat

5.9

23.5

R50.9

ICD-10 Finland

Fever, unspecified

1.7

23.5

455

2792

J01DB01

ATC

cefalexin; oral

1.5

23.3

2857

25688

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.9

23.2

107

371

R4130

NOMESCO Finland

Speech therapy

2.9

23.0

110

389

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

22.9

L01XE05

ATC

[U] sorafenib

+∞

22.9

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

22.9

WA039

NOMESCO Finland

Radiotherapy with free isotopes

+∞

22.9

R49.01

ICD-10 Finland

Functional dysphonia

2.5

22.7

139

559

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

231.4

22.6

R49.08

ICD-10 Finland

Other specified dysphonia

2.9

22.5

107

378

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

32.5

22.4

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.7

22.4

123

469

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.7

22.3

191

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

24.0

22.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

21.9

207

1003

L01AX03

ATC

temozolomide; systemic

+∞

21.9

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

21.9

C75.3

ICD-10 Finland

Malignant neoplasm: Pineal gland

+∞

21.9

1930B

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA FOLLICULARE THYREOIDEAE]

+∞

21.9

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

21.9

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

21.9

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

62.9

21.8

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

29.2

21.8

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

38.9

21.7

E20.8

ICD-10 Finland

Other hypoparathyroidism

38.9

21.7

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

80.6

21.7

E07.9

ICD-10 Finland

Disorder of thyroid, unspecified

6.9

21.6

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

7.4

21.6

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

115.7

21.6

XKD00

NOMESCO Finland

Uroflowmetry

1.8

21.5

327

1869

KAC10

NOMESCO Finland

Total nephrectomy with capsule

31.3

21.5

GBB00

NOMESCO Finland

Tracheostomy

5.2

21.4

3025

Kela drug reimbursment

Calcium carbonate

6.6

21.3

R13

ICD-10 Finland

Dysphagia

1.9

21.1

260

1387

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

50.3

21.1

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

20.8

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

20.8

L01CA04

ATC

vinorelbine; systemic

+∞

20.8

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

20.8

H01CB03

ATC

lanreotide; parenteral

211.2

20.6

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

211.2

20.6

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

20.6

2435

21413

E04.8

ICD-10 Finland

Other specified nontoxic goitre

6.7

20.4

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

3.5

20.1

205

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.5

20.1

107

E23.00

ICD-10 Finland

Panhypopituitarism

8.0

20.0

Z50.5

ICD-10 Finland

Speech therapy

3.7

20.0

168

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

6.0

19.9

T73

ICPC

Neoplasm endocrine other/unspecified

57.8

19.9

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

35.9

19.8

L02BA03

ATC

fulvestrant; parenteral

+∞

19.8

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

19.8

XX1XN

NOMESCO Finland

Other isotope examination

+∞

19.8

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

19.8

BA2MN

NOMESCO Finland

Thyroid radiation dose measurement during isotope therapy

+∞

19.8

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

19.8

1AB01, ,

NOMESCO Finland

+∞

19.8

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

19.8

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

19.7

335

1978

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

19.7

238

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

8.2

19.6

RL210, ,

NOMESCO Finland

6.6

19.6

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

6.6

19.6

M05BX04

ATC

denosumab; parenteral

2.1

19.5

193

952

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

17.8

19.5

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

19.4

210

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

8.4

19.3

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

19.2

156

712

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

7.0

19.1

BAA30

NOMESCO Finland

Excision of thyroid isthmus

20.1

19.0

WX720

NOMESCO Finland

Own respiration

2.1

18.9

180

876

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

18.8

239

1288

8010/3-C73.9

ICD-O-3

Carcinoma, NOS, of thyroid gland

+∞

18.8

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

18.8

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

18.8

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

18.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

18.7

276

1560

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.8

18.7

A02BC02

ATC

pantoprazole; systemic

1.4

18.6

2294

20121

C82.1

ICD-10 Finland

Follicular lymphoma grade II

191.0

18.5

WX400

NOMESCO Finland

Inhalation anesthesy

2.3

18.4

144

647

J01MA12

ATC

levofloxacin; systemic

1.6

18.2

519

3498

T81

ICPC

Goitre

6.1

18.1

UJF32

NOMESCO Finland

Coloscopy

1.5

18.1

793

5842

H02AA02

ATC

fludrocortisone; oral

4.6

18.0

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.9

17.9

300

B01AB04

ATC

dalteparin; parenteral

2.2

17.9

153

713

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.3

17.8

109

ZZF00

NOMESCO Finland

Graft of adipose tissue

7.0

17.8

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

17.7

L02BX02

ATC

degarelix; parenteral

+∞

17.7

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

17.7

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

17.7

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

17.7

Z2221

NOMESCO Finland

Medical doctor

1.4

17.6

846

6335

YX9AW, ,

NOMESCO Finland

95.5

17.6

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.4

17.5

Z3231

NOMESCO Finland

Registered nurse

1.4

17.5

796

5902

S04

ICPC

Lump/swelling localized

1.7

17.4

374

2352

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

17.0

17.4

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.3

17.3

200

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

3.5

17.3

166

EP1DM

NOMESCO Finland

Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet

42.2

17.3

101

Kela drug reimbursment

Anterior pituitary hypofunction

5.2

17.2

T85

ICPC

Hyperthyroidism/thyrotoxicosis

4.6

17.0

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

2.0

17.0

196

1023

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

50.2

17.0

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

4.0

17.0

122

4701

FHL

Neck lymph node removal

25.7

16.9

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.2

16.8

214

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

63.6

16.7

ZXB10

NOMESCO Finland

Medial

6.3

16.7

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

16.7

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

16.7

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

16.7

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

16.7

L01CB01

ATC

etoposide; systemic

+∞

16.7

9500/3-C74.1

ICD-O-3

Neuroblastoma, NOS, of medulla of adrenal gland

+∞

16.7

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

90.5

16.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

90.5

16.6

BC1CD

NOMESCO Finland

Very extensive CT of adrenal glands

7.0

16.5

EP1CM

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with 3 Tesla magnet

23.1

16.4

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

1.7

16.2

320

1966

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.6

16.1

N63

ICD-10 Finland

Unspecified lump in breast

1.9

16.1

207

1121

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

16.0

911

7010

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

1.9

16.0

220

1218

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

15.6

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

15.6

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

15.6

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

15.6

L01EX02

ATC

sorafenib; oral

+∞

15.6

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

15.6

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

15.6

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

15.6

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

15.6

C75.1

ICD-10 Finland

Malignant neoplasm: Pituitary gland

+∞

15.6

XX1AD

NOMESCO Finland

Other CT-examination

85.5

15.6

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.9

15.5

241

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

160.7

15.5

D35.59

ICD-10 Finland

Other paragangliom

160.7

15.5

2419X

ICD-9 Finland

Non-toxic nodular goitre, Unspecified non-toxic nodular goitre

6.2

15.5

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.5

15.3

155

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

13.1

15.2

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

13.1

15.2

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

15.1

394

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

2.1

15.1

141

682

L02AE03

ATC

goserelin; implant

5.0

15.0

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

15.0

223

1265

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.5

14.8

144

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

56.9

14.8

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

14.8

643

4711

N02AA01

ATC

morphine; systemic, rectal

4.0

14.8

103

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

18.4

14.7

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

14.6

444

3025

BC5AQ

NOMESCO Finland

Chromaffine tissue SPECT with low dose CT

+∞

14.6

L02BB04

ATC

enzalutamide; oral

+∞

14.6

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

14.6

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

14.6

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

14.6

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

14.6

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

14.6

8680/3-C75.5

ICD-O-3

Paraganglioma, NOS, of aortic body and other paraganglia

+∞

14.6

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

14.6

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

+∞

14.6

HAE99

NOMESCO Finland

Other reconstruction of breast

14.2

14.5

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

14.5

261

1565

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

150.6

14.5

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

150.6

14.5

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

36.2

14.4

H01CB02

ATC

octreotide; parenteral

36.2

14.4

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.5

14.4

142

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

3.2

14.4

177

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

14.3

933

7319

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

3.5

14.3

138

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

17.0

14.3

D45

ICD-10 Finland

Polycythaemia vera

19.2

14.2

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

10.9

14.0

R4190

NOMESCO Finland

Nutritional therapy

2.2

13.9

111

504

UDQ02

NOMESCO Finland

Direct laryngoscopy

4.1

13.9

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

30.1

13.9

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.4

13.8

141

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

53.5

13.8

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

13.6

361

2384

EL4AT

NOMESCO Finland

Salivary gland cytology with ultrasound guidance

6.5

13.6

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

13.6

1338

11142

394

Kela drug reimbursment

Palbociclib

+∞

13.5

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

13.5

153

Kela drug reimbursment

Lenalidomid

+∞

13.5

L01XE29

ATC

[U] lenvatinib

+∞

13.5

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

13.5

8335/3-C73.9

ICD-O-3

Follicular carcinoma, minimally invasive of thyroid gland

+∞

13.5

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

13.5

1CD02, ,

NOMESCO Finland

+∞

13.5

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

13.5

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

13.5

L04AX04

ATC

lenalidomide; oral

+∞

13.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

13.5

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

13.5

276

1710

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

140.5

13.5

WW300

NOMESCO Finland

Transfer of autologic stem cells

140.5

13.5

2410A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic uninodular goitre

10.1

13.4

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

16.2

13.4

BC1AD

NOMESCO Finland

CT of adrenal glands

3.6

13.1

117

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.7

13.1

270

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

13.1

1695

14628

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.0

13.0

146

756

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.3

12.9

417

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

22.6

12.9

2397A

ICD-9 Finland

Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system

22.6

12.9

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

50.2

12.8

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.4

12.8

345

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.5

12.8

309

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

5.1

12.7

R11

ICD-10 Finland

Nausea and vomiting

1.6

12.6

274

1726

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

70.1

12.6

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

70.1

12.6

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

70.1

12.6

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

6.0

12.6

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

12.5

C75.8

ICD-10 Finland

Malignant neoplasm: Pluriglandular involvement, unspecified

+∞

12.5

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

12.5

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

12.5

1501

Kela drug reimbursment

Palbociclib

+∞

12.5

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

12.5

329

Kela drug reimbursment

Lenalidomide

+∞

12.5

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

12.5

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

12.5

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

12.5

192

Kela drug reimbursment

Fulvestrant

+∞

12.5

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

12.5

BC5AN

NOMESCO Finland

Chromaffine and adrenergic tissue isotope imaging (MIBG)

+∞

12.5

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

12.5

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

12.5

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

24.4

12.5

S77

ICPC

Malignant neoplasm of skin

20.1

12.4

FM1FN

NOMESCO Finland

Heart function isotope examination

130.5

12.4

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

130.5

12.4

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

12.4

406

2809

UDC00

NOMESCO Finland

Ear microscopy

1.7

12.3

231

1400

ZZR10

NOMESCO Finland

Flap of skin and muscle

14.4

12.3

J37.0

ICD-10 Finland

Chronic laryngitis

2.1

12.2

115

559

E26.0

ICD-10 Finland

Primary hyperaldosteronism

4.4

12.1

N02AX02

ATC

tramadol; systemic, rectal

1.3

12.1

1307

10974

GAB20

NOMESCO Finland

Median sternotomy

26.8

12.0

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.5

12.0

312

2260A

ICD-9 Finland

Benign neoplasm of thyroid gland[NEOPLASMA BENIGNUM GLANDULAE THYREOIDEAE]

11.1

12.0

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

9.3

12.0

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

4.4

11.9

H05BX01

ATC

cinacalcet; oral

4.5

11.9

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.9

11.9

182

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

4.6

11.6

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

30.1

11.6

E04

ICD-10 Finland

Other nontoxic goitre

5.5

11.6

C08CA01

ATC

amlodipine; oral

1.3

11.6

1187

9883

XJH00

NOMESCO Finland

Transanal ultrasonography

2.1

11.6

106

510

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.7

11.6

218

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

11.5

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

11.5

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

11.5

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

11.5

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

11.5

197

Kela drug reimbursment

Sunitinib

+∞

11.5

L03AB05

ATC

interferon alfa-2b; parenteral

+∞

11.5

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

11.5

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

11.5

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

11.5

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

11.5

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

11.5

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

11.5

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

11.3

209

1261

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.2

11.3

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

11.2

118

599

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.5

11.1

269

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

20.1

11.1

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.6

11.1

-1, ,

ICD-10 Finland

1.9

11.0

147

808

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

11.0

196

1173

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.3

10.9

122

ELB40

NOMESCO Finland

Partial parotidectomy

3.3

10.9

122

2533

FHL

Unilateral removal of additional egg

43.4

10.9

TQW99

NOMESCO Finland

Other minor procedure on skin

2.1

10.9

104

509

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.9

10.8

175

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

10.8

239

1513

ENB50

NOMESCO Finland

Excision of cyst or fistula of thyroglossic duct

10.6

10.8

J01MA02

ATC

ciprofloxacin; systemic

1.3

10.7

1133

9452

GEB30

NOMESCO Finland

Mediastinotomy and excision of lesion

21.5

10.7

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

21.5

10.7

E89.0

ICD-10 Finland

Postprocedural hypothyroidism

12.9

10.6

E34.0

ICD-10 Finland

Carcinoid syndrome

60.2

10.6

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.1

10.6

140

BA3AT, ,

SPAT

10.0

10.5

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

14.2

10.5

EP1AT

NOMESCO Finland

Punction of soft tissue of neck with ultrasound guidance

14.2

10.5

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

110.3

10.4

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

110.3

10.4

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

110.3

10.4

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

10.4

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

10.4

D09.3

ICD-10 Finland

Carcinoma in situ: Thyroid and other endocrine glands

+∞

10.4

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

10.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

10.4

8339/3-C73.9

ICD-O-3

Follicular carcinoma, encapsulated, angioinvasive of thyroid gland

+∞

10.4

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

10.4

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

10.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

10.4

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

10.4

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

10.4

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

10.4

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

10.4

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

10.4

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

7.7

10.4

KAD00

NOMESCO Finland

Partial nephrectomy

12.1

10.3

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

32.6

10.3

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

3.1

10.3

137

HAD99

NOMESCO Finland

Other plastic operation on breast

8.2

10.3

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

3.5

10.2

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

10.1

149

N05CF01

ATC

zopiclone; oral

1.3

10.1

953

7828

BAA50

NOMESCO Finland

Lobectomy and resection of contralateral lobe of thyroid gland

11.3

10.0

HA1HA

NOMESCO Finland

Tomosynthesis mammography

11.3

10.0

Q18.0

ICD-10 Finland

Sinus, fistula and cyst of branchial cleft

4.8

10.0

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

40.2

10.0

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.0

9.9

146

GB1AA

NOMESCO Finland

Tracheal X-ray examination

16.7

9.9

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

9.9

1939

17361

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

9.8

1135

9553

GDC00

NOMESCO Finland

Lobectomy of lung

26.1

9.8

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

20.1

9.8

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

4.7

9.8

2411A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic multinodular goitre

4.7

9.8

WX002

NOMESCO Finland

Sedation and analgesia

1.4

9.8

542

4120

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

13.4

9.7

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

55.1

9.6

R04.2

ICD-10 Finland

Haemoptysis

2.1

9.6

451

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.8

9.6

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

2.3

9.6

308

UGB02

NOMESCO Finland

Tracheoscopy

11.4

9.5

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.5

9.5

223

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

15.1

9.5

23914

ICD-8 Finland

Neoplasm of unspecified nature of other and unspecified organs, Glandulae thyreoideae

100.3

9.4

C20

ICD-10 Finland

Malignant neoplasm of rectum

100.3

9.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

9.4

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

9.4

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

9.4

WW402

NOMESCO Finland

Leucoferesis

+∞

9.4

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

9.4

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

9.4

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

9.4

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

9.4

L01XE01

ATC

[U] imatinib

+∞

9.4

L01EF01

ATC

palbociclib; oral

+∞

9.4

JN5FN

NOMESCO Finland

Scintigraphy of thyroid metastases in connection with ablation

+∞

9.4

189

Kela drug reimbursment

Imatinib

+∞

9.4

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

9.4

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

9.4

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

9.4

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

9.4

L02BX03

ATC

abiraterone; oral

+∞

9.4

180

Kela drug reimbursment

Interferon alfa

+∞

9.4

C75

ICD-10 Finland

Malignant neoplasm of other endocrine glands and related structures

+∞

9.4

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

9.4

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

2.6

9.3

196

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

9.3

383

L91.0

ICD-10 Finland

Hypertrophic scar

2.9

9.2

147

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

7.7

9.1

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.0

9.1

126

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

9.0

144

837

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

9.0

907

7495

DQE20

NOMESCO Finland

Implantation of foreign material in vocal chord

18.6

8.9

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

4.2

8.9

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

12.5

8.9

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.2

8.8

345

105

Kela drug reimbursment

Adrenal cortical hypofunction

8.6

8.8

C07AA05

ATC

propranolol; systemic

1.3

8.8

637

5035

E20

ICD-10 Finland

Hypoparathyroidism

50.1

8.7

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

50.1

8.7

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

8.7

259

1757

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.7

8.6

169

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

8.6

1158

9894

D75

ICPC

Malignant neoplasm colon/rectum

16.3

8.5

205

Kela drug reimbursment

Chronic hypertension

1.3

8.5

712

5735

R53

ICD-10 Finland

Malaise and fatigue

1.3

8.5

785

6406

TQW40, ,

SPAT

1.5

8.5

289

2012

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.6

8.5

188

KKB10

NOMESCO Finland

Excision of retroperitoneal tumour

20.1

8.5

A02BC05

ATC

esomeprazole; systemic

1.2

8.4

1294

11208

WX1CG

NOMESCO Finland

Extensive total body MRI with high intensity magnet

90.3

8.4

D30.0

ICD-10 Finland

Benign neoplasm: Kidney

3.1

8.4

106

ZX121

NOMESCO Finland

Central venous catheter

12.8

8.4

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.0

8.3

455

E06.3

ICD-10 Finland

Autoimmune thyroiditis

3.2

8.3

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

8.3

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

8.3

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

8.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

8.3

2374A

ICD-9 Finland

Neoplasm of uncertain behaviour of endocrine glands and nervous system, Other and unspecified endocrine glands

+∞

8.3

C76.0

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Head, face and neck

+∞

8.3

19300, ,

ICD-8 Finland

+∞

8.3

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

8.3

8344/3-C73.9

ICD-O-3

Papillary carcinoma, columnar cell of thyroid gland

+∞

8.3

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

+∞

8.3

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

8.3

L01XE33

ATC

[U] palbociclib

+∞

8.3

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

8.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

8.3

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

8.3

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

8.3

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

8.3

C09.9

ICD-10 Finland

Malignant neoplasm: Tonsil, unspecified

+∞

8.3

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

8.3

1940B

ICD-9 Finland

Malignant neoplasm of other endocrine glands and related structures, Adrenal gland[NEUROBLASTOMA SUPRARENALIS]

+∞

8.3

L01EA01

ATC

imatinib; oral

+∞

8.3

TKE10

NOMESCO Finland

Puncture of prostate

+∞

8.3

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

8.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

8.3

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

8.3

C75.2

ICD-10 Finland

Malignant neoplasm: Craniopharyngeal duct

+∞

8.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

8.3

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

+∞

8.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

8.3

5639

FHL

Other measure in this category

+∞

8.3

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.0

8.3

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.6

8.3

184

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

1.7

8.3

161

987

K11.2

ICD-10 Finland

Sialoadenitis

1.8

8.3

109

598

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.9

8.3

128

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.6

8.2

185

H02AB06

ATC

prednisolone; systemic

1.2

8.2

1472

12950

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

8.2

827

6819

UKC02

NOMESCO Finland

Cystoscopy

1.4

8.1

349

2538

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

4.5

8.1

WX892

NOMESCO Finland

Monitored bed care

1.6

8.1

191

1229

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

33.4

8.1

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

17.2

8.1

E24.9

ICD-10 Finland

Cushing syndrome, unspecified

17.2

8.1

WX734

NOMESCO Finland

JET-ventilation

11.7

8.1

ZXD05

NOMESCO Finland

Urgent procedure

1.3

8.1

852

7066

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

6.8

8.1

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

8.9

8.0

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

22.1

8.0

T72

ICPC

Benign neoplasm thyroid

6.3

8.0

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

7.2

7.9

S21

ICPC

Skin texture symptom/complaint

1.4

7.9

444

3374

DHB00

NOMESCO Finland

Excision of lesion of external nose

6.6

7.9

E24.8

ICD-10 Finland

Other Cushing syndrome

13.0

7.9

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

7.9

319

2297

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

6.1

7.8

R07.0

ICD-10 Finland

Pain in throat

1.5

7.8

223

1498

I15.2

ICD-10 Finland

Hypertension secondary to endocrine disorders

9.4

7.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

7.7

316

2278

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

45.1

7.7

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

45.1

7.7

D77

ICPC

Malignant digestive neopl other/NOS

45.1

7.7

L02AE04

ATC

triptorelin; parenteral

45.1

7.7

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.4

7.7

210

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

7.7

137

823

R21

ICPC

Throat symptom/complaint

1.3

7.6

645

5196

2509

FHL

Other measure in this category

18.4

7.6

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

7.6

105

586

R06.0

ICD-10 Finland

Dyspnoea

1.3

7.6

825

6859

OAA41

NOMESCO Finland

Health check based on individual needs

25.1

7.6

M05BA02

ATC

clodronic acid; systemic

25.1

7.6

UDQ22

NOMESCO Finland

Microlaryngoscopy

3.6

7.6

J38.3

ICD-10 Finland

Other diseases of vocal cords

2.8

7.5

135

ELB50

NOMESCO Finland

Total parotidectomy

10.0

7.5

E05.4

ICD-10 Finland

Thyrotoxicosis factitia

10.0

7.5

WF099

NOMESCO Finland

Other radiotherapy

10.0

7.5

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.7

7.5

132

789

ZXC50

NOMESCO Finland

Cryotherapy

2.2

7.5

263

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

7.1

7.5

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

7.1

7.5

C07AB07

ATC

bisoprolol; oral

1.2

7.4

1462

12944

Q85.82

ICD-10 Finland

of Hipple-Lindau syndrome

80.3

7.4

JJB71

NOMESCO Finland

Laparoscopic resection of liver

80.3

7.4

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

80.3

7.4

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

80.3

7.4

1XC03, ,

NOMESCO Finland

80.3

7.4

V04CD01

ATC

metyrapone; oral

80.3

7.4

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.5

7.4

A06AD11

ATC

lactulose; oral

1.4

7.4

366

2728

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

3.3

7.4

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.6

7.4

154

E21.2

ICD-10 Finland

Other hyperparathyroidism

4.0

7.3

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

7.3

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

7.3

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

7.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

7.3

8317/3-C64.9

ICD-O-3

Renal cell carcinoma, chromophobe type of kidney, NOS

+∞

7.3

C75.5

ICD-10 Finland

Malignant neoplasm: Aortic body and other paraganglia

+∞

7.3

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

7.3

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

7.3

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

7.3

C48.00

ICD-10 Finland

Malignant tumor of the retroperitoneal space without histology

+∞

7.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

7.3

8370/3-C74.9

ICD-O-3

Adrenal cortical carcinoma of adrenal gland, NOS

+∞

7.3

C56

ICD-10 Finland

Malignant neoplasm of ovary

+∞

7.3

XX7HT

NOMESCO Finland

Chromaffine tissue (MIBG) isotope therapy

+∞

7.3

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

7.3

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

7.3

1930D

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA MEDULLARE THYREOIDEAE]

+∞

7.3

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

7.3

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

7.3

9680/3-C73.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of thyroid gland

+∞

7.3

8010/3-C74.9

ICD-O-3

Carcinoma, NOS, of adrenal gland, NOS

+∞

7.3

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

7.3

3012

Kela drug reimbursment

Cabozantinib

+∞

7.3

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

7.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

7.3

L01EX07

ATC

cabozantinib; oral

+∞

7.3

8021/3-C73.9

ICD-O-3

Carcinoma, anaplastic, NOS, of thyroid gland

+∞

7.3

8272/3-C75.1

ICD-O-3

Pituitary carcinoma, NOS, of pituitary gland

+∞

7.3

4707

FHL

Dissection Colli radicalis

+∞

7.3

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

7.3

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

+∞

7.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

7.3

C09.0

ICD-10 Finland

Malignant neoplasm: Tonsillar fossa

+∞

7.3

C64.80

ICD-10 Finland

Wilms tumour

+∞

7.3

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

7.3

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

7.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

7.3

322

Kela drug reimbursment

Sunitinib

+∞

7.3

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

7.3

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

7.3

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

7.3

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

7.3

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

7.3

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

7.3

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

10.9

7.3

TPX15

NOMESCO Finland

Removal of vascular injection port

9.4

7.3

R31

ICD-10 Finland

Unspecified haematuria

1.5

7.2

216

1467

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

7.2

388

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

2.2

7.2

248

J01FA10

ATC

azithromycin; systemic

1.2

7.2

1869

16982

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.6

7.2

143

885

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

3.9

7.2

P01AB01

ATC

metronidazole; oral, rectal

1.2

7.2

1270

11120

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

30.1

7.1

D44.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Parathyroid gland

20.0

7.1

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

7.1

161

1028

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

7.9

7.1

Z43.0

ICD-10 Finland

Attention to tracheostomy

7.9

7.1

DWD00

NOMESCO Finland

Reoperation for superficial heamorrhage in surgery of ear, nose and larynx

12.0

7.1

WPB10

NOMESCO Finland

Making a convalescent care decision

12.0

7.1

KAC00

NOMESCO Finland

Nephrectomy

12.0

7.1

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

7.0

3075

29441

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.7

7.0

129

Z2446

NOMESCO Finland

Social worker

1.6

7.0

161

1033

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.4

7.0

201

B02AA02

ATC

tranexamic acid; systemic

1.3

6.9

462

3602

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.6

6.9

153

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

6.9

173

1130

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.5

6.9

171

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

7.5

6.9

UJC12

NOMESCO Finland

Flexible oesophagoscopy

3.3

6.8

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

4.1

6.8

R01AD09

ATC

mometasone; nasal

1.2

6.8

1473

13131

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

6.8

144

905

JAH00

NOMESCO Finland

Laparotomy

2.1

6.8

274

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

6.1

6.8

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

40.1

6.8

KEB00

NOMESCO Finland

Biopsy of prostate

5.6

6.7

A01AB09

ATC

miconazole; local oral

1.5

6.7

239

1681

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.5

6.6

157

9101

FHL

Bone biopsy

10.0

6.5

J02AC01

ATC

fluconazole; systemic

1.2

6.5

1313

11611

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.8

6.5

534

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

6.2

6.5

C74

ICD-10 Finland

Malignant neoplasm of adrenal gland

70.0

6.4

D35.50

ICD-10 Finland

Carotid body

70.0

6.4

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

70.0

6.4

JJB10

NOMESCO Finland

Atypcal resection of liver

70.0

6.4

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

70.0

6.4

RS220, ,

NOMESCO Finland

2.5

6.4

153

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

6.4

339

2553

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.9

6.4

JLC10

NOMESCO Finland

Distal pancreatectomy

14.3

6.4

HA1SA

NOMESCO Finland

Expansion mammography

14.3

6.4

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

14.3

6.4

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

6.4

377

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.8

6.4

558

XQ845

NOMESCO Finland

Dermatoscopy

2.3

6.4

203

Q18.8

ICD-10 Finland

Other specified congenital malformations of face and neck

6.5

6.3

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

8.1

6.3

C03CA01

ATC

furosemide; systemic

1.2

6.3

760

6378

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

11.0

6.3

J01FA09

ATC

clarithromycin; systemic

1.2

6.3

967

8327

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

2.5

6.3

143

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

2.0

6.3

324

2502

FHL

Thyroid exploration and possible biopsy

18.0

6.3

C73, C75,

ICD-10 Finland

+∞

6.2

XX2ET, ,

NOMESCO Finland

+∞

6.2

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

+∞

6.2

1523, ,

Kela drug reimbursment

+∞

6.2

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

6.2

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

6.2

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

6.2

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

6.2

JN4DD

NOMESCO Finland

Scout CT scan of torso

+∞

6.2

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

6.2

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

6.2

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

6.2

L01EX01

ATC

sunitinib; oral

+∞

6.2

JN5AP

NOMESCO Finland

Total body PET (1 picture)

+∞

6.2

HAC25

NOMESCO Finland

Radical mastectomy

+∞

6.2

8520/3-C50.8

ICD-O-3

Lobular carcinoma, NOS, of overlapping lesion of breast

+∞

6.2

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

+∞

6.2

C45.0

ICD-10 Finland

Mesothelioma of pleura

+∞

6.2

WE100

NOMESCO Finland

Profylactic cytostatic therapy

+∞

6.2

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

6.2

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

6.2

JN4LR

NOMESCO Finland

Extensive PET-CT of receptors in whole body

+∞

6.2

1930A, ,

ICD-10 Finland

+∞

6.2

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

6.2

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

6.2

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

+∞

6.2

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

6.2

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

6.2

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

6.2

8140/3-C75.0

ICD-O-3

Adenocarcinoma, NOS, of parathyroid gland

+∞

6.2

JN7SN

NOMESCO Finland

Somatostatin receptor SPECT

+∞

6.2

3054, ,

Kela drug reimbursment

+∞

6.2

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

6.2

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

6.2

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

6.2

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

6.2

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.4

6.2

235

1671

JN4SR

NOMESCO Finland

Very extensive PET-CT of receptors in whole body

26.7

6.2

ZSP00

NOMESCO Finland

Procedure related to previous procedure classified in chapter P

26.7

6.2

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

2.0

6.2

311

G04CA02

ATC

tamsulosin; oral

1.3

6.2

421

3289

S29

ICPC

Skin symptom/complaint other

1.3

6.2

593

4844

AA1AA

NOMESCO Finland

Head X-ray examination

3.1

6.2

K22.2

ICD-10 Finland

Oesophageal obstruction

3.2

6.1

RD210, ,

NOMESCO Finland

2.2

6.1

220

KED22

NOMESCO Finland

Transurethral resection of prostate

1.8

6.1

507

JG1BG

NOMESCO Finland

MRI of rectum

12.5

6.1

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.0

6.1

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

8.6

6.0

GAA31

NOMESCO Finland

Thoracoscopy

8.6

6.0

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

6.0

472

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

3.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1988

2151

19.28

307.65

7.8

3.1

4.50

pmol/l

0.04

1941

1921

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

842

461

23.50

307.65

1.6

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

2202

153

365.86

307.65

8.7

1.2

46.75

115.60

u/ml

0.75

909

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1047

2499

5.49

307.65

3.6

3.8

53.79

87.15

ng/l

39.72

944

2156

(3018418) pH of Serum or Plasma

2188

8933

4.66

307.65

8.6

3.4

7.40

0.45

1751

6318

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2688

13385

4.92

307.65

11.1

5.9

1.20

1.22

mmol/l

27.45

2610

12210

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2904

15140

5.64

307.65

13.5

6.2

1.20

1.22

mmol/l

40.55

2558

13072

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2184

1774.49

307.65

8.2

1.2

70.52

71.57

ug/l

0.01

1397

(4035726) Immunohistochemistry procedure

879

899

12.59

307.65

1.5

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2012

10187

3.20

254.54

4.9

2.1

2.31

2.36

mmol/l

41.91

1902

9042

(3002256) Pathology report gross observation

836

2692

3.74

218.14

1.5

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2199

13296

2.67

174.73

3.0

2.4

—

estimate

—

(40768804) Tissue Pathology biopsy report

1935

11048

2.61

172.37

2.5

1.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

186

182

10.72

168.14

4.5

1.7

5.52

3.56

nmol/l

1.03

180

172

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3355

25939

5.01

163.74

12.8

4.6

17.38

14.71

pmol/l

307.65

3268

24011

(3044640) Blood type and Crossmatch panel - Blood

1647

8878

2.57

162.94

2.6

2.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1032

4428

2.86

161.24

4.2

2.8

0.81

0.82

mmol/l

3.41

995

4113

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

514

1454

3.95

158.77

4.8

1.5

22.03

2.61

ug/l

1.27

395

1074

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

104

23.25

143.50

3.9

1.0

25.74

13.58

u/ml

3.32

104

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

239

417

6.07

131.77

3.4

1.2

1.56

0.19

nmol/l

0.76

188

333

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

253

484

5.54

126.47

3.6

1.3

1.36

6.64

nmol/l

0.64

248

466

(3024561) Albumin [Mass/volume] in Serum or Plasma

2036

13049

2.28

125.16

6.2

4.0

36.29

36.35

g/l

0.19

1951

12111

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

253

501

5.35

121.67

3.6

1.3

0.36

0.37

nmol/l

0.03

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

600

2258

2.99

115.74

7.5

3.0

1.21

1.23

mmol/l

13.44

558

1882

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2240

15343

2.21

111.41

3.3

2.5

78.10

78.13

nmol/l

0.02

2125

13900

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2188

14873

2.19

110.61

8.3

3.9

10.76

11.20

umol/l

0.82

2114

13985

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1234

6697

2.28

110.11

2.5

2.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

217

422

5.41

106.30

3.4

1.3

—

nmol/l

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2353

16855

2.13

98.57

11.6

7.0

3.92

4.15

e9/l

5.81

2051

14453

(3003458) Phosphate [Moles/volume] in Serum or Plasma

790

3707

2.45

96.87

6.1

5.7

1.08

1.04

mmol/l

2.98

737

3399

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1096

5935

2.21

95.92

4.3

2.1

2.41

2.44

mmol/l

10.40

1009

5231

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2955

23332

2.45

95.23

11.2

5.9

78.09

76.23

u/l

1.79

2862

21886

(3010838) Calcium [Moles/time] in 24 hour Urine

252

619

4.30

92.99

2.4

2.1

5.81

5.12

mmol/24h

1.82

236

549

(40768795) Lymph node Pathology biopsy report

14.33

87.91

1.2

1.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2365

17904

1.93

73.26

6.0

4.6

6.50

6.63

mmol/l

2.47

2283

16821

(3033658) Prothrombin time (PT) actual/Normal

1174

7222

1.93

68.08

4.4

3.6

94.26

91.65

3.52

1158

7042

(3011985) Renin [Units/volume] in Plasma

188

472

4.15

67.15

2.5

1.4

59.00

63.88

mu/l

0.11

166

428

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3395

29974

3.13

64.66

16.4

5.6

1.58

1.89

mu/l

2.06

3284

27998

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

291

1004

3.06

63.93

2.5

2.1

4.10

9.11

iu/l

0.45

150

430

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

18.09

62.03

1.2

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

609

3050

2.20

61.50

3.7

1.9

381.97

371.96

nmol/l

0.27

581

2798

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

523

2497

2.28

59.19

5.5

2.4

236.38

229.03

u/l

0.77

501

2333

(40768793) Breast Pathology biopsy report

132

292

4.65

55.42

1.3

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

231

769

3.14

53.81

2.4

1.8

—

(3032080) INR in Blood by Coagulation assay

1801

13293

1.71

52.72

12.6

14.6

1.17

1.24

inr

7.21

1507

11014

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

161

444

3.75

50.36

1.4

1.3

273.02

333.17

pmol/l

1.94

138

388

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

183

578

3.28

46.46

3.3

2.1

448.91

22.48

u/ml

1.09

160

473

(3019977) pH of Arterial blood

561

3072

1.98

43.43

7.4

8.2

7.42

0.19

298

1731

(3027801) Oxygen [Partial pressure] in Arterial blood

560

3070

1.97

43.19

7.3

8.2

12.98

11.90

kpa

4.75

538

2941

(3023368) Bacteria identified in Blood by Culture

1067

7123

1.71

43.11

4.8

3.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

560

3072

1.97

43.10

7.3

8.2

5.15

5.07

kpa

1.47

538

2944

(3003396) Base excess in Arterial blood by calculation

556

3045

1.98

42.99

7.2

8.2

0.97

1.10

mmol/l

0.35

468

2485

(3019069) Monocytes/Leukocytes in Blood

1863

14373

1.61

42.05

7.5

6.2

8.75

8.66

0.69

1769

13416

(3002030) Lymphocytes/Leukocytes in Blood

1900

14748

1.61

41.65

7.4

6.1

27.64

28.69

3.86

1816

13916

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

518

2798

1.99

41.58

3.6

3.0

—

(3006504) Eosinophils/Leukocytes in Blood

1858

14349

1.61

41.58

7.5

6.1

2.82

2.95

1.45

1766

13384

(3003694) ABO and Rh group [Type] in Blood

1185

8270

1.64

39.71

1.5

—

(3022096) Basophils/Leukocytes in Blood

1850

14379

1.59

39.48

7.6

6.2

0.68

0.70

0.44

1754

13382

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

322

1481

2.29

39.13

8.5

10.9

16.41

16.04

1.51

312

1421

(3016502) Oxygen saturation in Arterial blood

500

2725

1.97

38.96

7.4

8.6

96.04

95.37

1.55

484

2622

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

37.56

1.0

0.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

443

2344

2.01

37.48

2.0

2.2

0.22

0.21

g/l

3.70

421

2162

(3019198) Lymphocytes [#/volume] in Blood

2021

16196

1.56

36.51

7.2

6.1

1.89

1.91

e9/l

0.20

1800

14255

(3002173) Hemoglobin [Mass/volume] in Arterial blood

464

2522

1.96

36.29

7.9

9.0

122.81

122.15

g/l

0.29

453

2457

(3042111) Morphology [Interpretation] in Bone marrow Narrative

216

4.34

35.87

1.5

1.2

—

(3001604) Monocytes [#/volume] in Blood

1978

15815

1.55

35.79

7.2

6.0

0.57

e9/l

0.10

1705

13585

(3013115) Eosinophils [#/volume] in Blood

2036

16390

1.55

35.68

7.5

6.1

0.19

0.20

e9/l

1.34

1800

14336

(3006315) Basophils [#/volume] in Blood

1981

15860

1.55

35.51

7.2

6.0

0.04

e9/l

1.11

1709

13622

(3018010) Neutrophils/Leukocytes in Blood

1839

14524

1.54

34.77

7.3

6.0

57.65

56.78

2.58

1777

13830

(40758558) Short blood count panel - Blood

1244

9084

1.56

33.05

7.6

4.7

—

(3045142) Bone marrow Pathology biopsy report

113

5.56

32.53

1.5

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

182

4.42

31.57

1.4

3.98

4.53

umol/l

0.52

165

(3012565) Volume of 24 hour Urine

131

5.03

30.52

2.7

2.1

1882.93

1973.61

0.31

117

(3021589) Normoblasts [#/volume] in Blood

1728

13834

1.48

28.26

15.7

9.6

0.00

e9/l

1.12

1425

11277

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1363

10484

1.48

26.87

3.6

3.2

—

1.64

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3396

31746

2.13

26.79

23.5

15.7

139.82

139.81

mmol/l

0.03

3360

31116

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

113

373

3.09

26.68

1.2

1.3

—

34.44

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

327

1754

1.95

26.25

9.4

25.16

24.90

mmol/l

0.63

322

1746

(3002582) Erythrocytes [#/volume] in Urine

1261

9597

1.48

26.00

3.6

3.2

45.48

61.34

e6/l

0.66

982

7190

(3023103) Potassium [Moles/volume] in Serum or Plasma

3395

31823

2.08

25.14

23.9

15.8

3.92

3.96

mmol/l

19.52

3348

31124

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

25.02

1.1

0.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

118

4.80

25.00

1.6

272.88

71.62

nmol/24h

1.63

118

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

636

4206

1.62

24.69

3.0

2.6

21.56

22.70

1.29

598

3884

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2901

26079

1.57

24.68

27.3

16.0

13.62

13.49

6.83

2881

25690

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3322

30961

1.89

24.25

20.9

13.2

21.88

21.62

mg/l

0.19

2891

24763

(3018677) aPTT in Platelet poor plasma by Coagulation assay

644

4294

1.61

24.11

2.7

2.0

29.77

29.40

0.74

628

4170

(3018095) Leukocytes [#/volume] in Urine

1431

11279

1.44

24.09

4.2

3.7

71.13

104.23

e6/l

1.02

1034

7647

(3026782) Osmolality of Urine

788

5509

1.55

24.03

2.9

2.8

512.81

519.90

mosm/kgh2o

0.41

694

4769

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

276

1439

1.99

24.01

2.6

1.5

44.95

22.76

u/ml

1.47

269

1375

(36304419) Bacteria [Presence] in Urine

1059

7891

1.48

23.82

3.4

3.0

6.78

328.37

estimate

—

(3030467) Casts [#/volume] in Urine by Automated count

1101

8274

1.48

23.70

3.5

3.0

0.38

e6/l

0.02

825

5970

(3047181) Lactate [Moles/volume] in Blood

189

860

2.26

23.42

5.1

6.3

1.32

1.26

mmol/l

0.26

166

753

(3000991) Gas panel - Venous blood

392

2333

1.76

22.49

9.2

—

(40768800) Prostate Pathology biopsy report

5.35

22.29

1.1

—

(3042936) Bacteria identified in Isolate by Culture

592

3942

1.60

22.12

2.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

178

814

2.25

21.80

6.1

4.0

1.56

1.53

mg/l

0.14

168

727

(3000850) Epithelial cells [#/volume] in Urine

906

6658

1.48

21.44

2.8

2.6

5.26

6.32

e6/l

1.70

822

6013

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

115

437

2.69

21.05

1.4

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

670

4643

1.54

20.93

2.9

2.6

2.35

2.37

g/l

0.54

630

4275

(3022948) Iron [Moles/volume] in Serum or Plasma

717

5043

1.53

20.92

2.9

2.6

12.40

13.40

umol/l

3.44

685

4673

(3031040) Bacteria [#/volume] in Urine by Automated count

2348

20521

1.41

20.54

5.1

4.6

3452.53

1956.33

e6/l

0.29

258

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

174

809

2.21

20.48

2.3

3.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

281

1554

1.88

20.48

9.2

10.2

24.34

24.30

mmol/l

0.09

275

1523

(3039000) Anion gap in Blood by calculation

134

561

2.44

20.10

5.7

7.8

11.11

11.40

mmol/l

0.38

124

498

(3018572) Chloride [Moles/volume] in Blood

134

562

2.44

20.02

5.7

7.8

105.61

104.71

mmol/l

1.98

124

499

(3008152) Bicarbonate [Moles/volume] in Arterial blood

296

1691

1.82

19.43

6.3

7.2

25.01

24.57

mmol/l

1.41

282

1613

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

168

3.68

19.24

1.7

1.9

8.50

6.04

nmol/l

0.42

130

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

655

4593

1.52

19.21

2.2

1.8

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2669

24017

1.42

18.61

4.9

4.5

12.28

11.31

mm/h

2.81

2513

22549

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3201

29894

1.61

18.36

21.4

12.4

82.37

81.42

ml/min/173m2

1.82

3039

27402

(40761536) Microorganisms panel - Urine sediment

378

2353

1.68

18.30

4.2

3.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

513

3455

1.56

17.99

2.0

1.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

380

2382

1.67

17.90

9.2

7.8

9.42

9.81

mmol/l

0.51

355

2287

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1228

9789

1.39

17.88

2.9

2.4

59.54

58.70

u/l

0.10

1139

9033

(3019060) Gas panel - Arterial blood

276

1584

1.80

17.83

4.5

5.3

—

(3019225) pH of Specimen

436

2839

1.61

17.64

8.9

3.6

7.37

7.35

0.93

392

1861

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

486

3254

1.57

17.46

2.0

1.8

—

(3002032) Base excess in Venous blood by calculation

436

2854

1.60

17.24

5.4

3.8

2.25

1.92

mmol/l

1.22

381

2538

(3012544) pH of Venous blood

448

2964

1.58

16.92

5.4

3.9

7.38

0.38

260

1683

(3014111) Lactate [Moles/volume] in Serum or Plasma

381

2425

1.64

16.88

9.4

8.0

1.24

1.33

mmol/l

1.21

375

2380

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.84

16.82

1.5

1.1

37.73

0.72

umol/24h

0.51

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

222

3.06

15.84

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

389

2535

1.60

15.61

1.2

137.18

139.78

u/ml

0.04

146

1000

(3026008) Bacteria identified in Urine by Culture

1195

9667

1.35

15.27

3.1

3.2

—

(3022145) Colonoscopy Study observation

491

3389

1.52

15.25

1.4

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

279

2.76

14.96

1.3

1.2

120.12

110.01

pmol/l

0.27

279

(3007930) Methemoglobin/Hemoglobin.total in Blood

209

1166

1.84

14.81

5.2

5.3

0.92

0.88

1.10

199

1099

(3021447) Carbon dioxide [Partial pressure] in Venous blood

432

2922

1.54

14.71

5.5

3.8

5.91

5.84

kpa

0.67

417

2849

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1019

8104

1.36

14.36

2.5

2.4

2.87

2.71

mg/l

1.36

891

7035

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1271

10478

1.33

13.99

3.9

2.8

28.48

34.11

u/l

2.37

1206

9864

(3011412) CD3 cells [#/volume] in Blood

201

3.02

13.96

3.1

2.2

1224.52

1224.77

e6/l

0.00

176

(40760892) CBC W Ordered Manual Differential panel - Blood

900

7048

1.37

13.93

5.1

4.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

151

772

2.00

13.92

2.0

1.5

13.26

10.82

u/l

0.90

108

622

(3005719) IgG [Mass/volume] in Serum or Plasma

349

2280

1.59

13.82

3.7

2.5

10.34

10.67

g/l

0.56

323

2108

(3004809) Band form neutrophils/Leukocytes in Blood

298

2.62

13.71

3.8

2.5

2.56

0.99

1.55

255

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

4.37

13.32

1.2

12.73

11.25

pmol/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

273

1694

1.66

13.31

2.6

2.2

10.71

13.64

nmol/l

6.25

249

1546

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

218

1272

1.76

13.31

5.2

5.1

1.62

1.61

0.05

208

1202

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

614

4546

1.42

13.18

3.2

2.9

4.28

3.44

e6/l

0.55

291

2108

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

5.13

13.15

3.3

2.5

1.48

0.76

1.32

(3035715) Granulocytes [#/volume] in Blood

103

467

2.24

12.99

3.1

3.5

3.94

3.98

e9/l

0.08

103

467

(3037756) Immunofixation for Serum or Plasma

104

474

2.23

12.95

1.9

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

143

3.32

12.84

1.5

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

128

639

2.04

12.63

1.9

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

138

708

1.99

12.62

4.0

4.4

8.40

8.34

kpa

0.17

138

692

(3017181) Myelocytes/Leukocytes in Blood

377

2559

1.53

12.57

4.6

4.3

1.26

0.58

3.85

119

511

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

476

3396

1.46

12.43

2.9

2.3

6.99

6.77

umol/l

0.08

418

2907

(3020630) Protein [Mass/volume] in Serum or Plasma

343

2288

1.55

12.38

3.3

1.6

66.26

67.02

g/l

1.04

321

2068

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

332

2.44

12.36

3.4

2.2

535.98

25.53

u/ml

0.92

296

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

152

3.19

12.31

2.5

2.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

309

2.49

12.27

1.8

1.4

—

(3002179) Metamyelocytes/Leukocytes in Blood

362

2454

1.53

12.14

4.2

4.1

1.22

0.49

1.95

112

500

(3035933) Granulocytes/Leukocytes in Blood

117

579

2.05

11.84

3.2

58.36

57.57

0.26

117

579

(3021901) Oxygen saturation in Capillary blood

113

552

2.08

11.84

3.5

3.2

90.72

90.12

0.43

113

537

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

454

2.19

11.76

1.8

1.4

0.33

0.41

nmol/l

0.57

369

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1790

15694

1.28

11.67

3.6

3.1

119.52

100.68

ug/l

2.36

1673

14728

(3021440) Promyelocytes/Leukocytes in Blood

363

2485

1.51

11.61

4.6

4.4

0.18

0.05

1.47

105

439

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

670

5140

1.37

11.52

3.1

2.7

5.46

1.22

e6/l

0.45

347

2712

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.40

11.43

1.3

1.4

—

(1616796) Gas panel - Central venous blood

115

574

2.04

11.39

4.7

3.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.92

11.20

1.6

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

166

942

1.80

11.18

2.3

1.8

11.00

1.71

ug/l

0.55

148

815

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

132

697

1.93

11.14

2.0

1.7

—

(3027945) Reticulocytes/Erythrocytes in Blood

423

3014

1.46

11.07

3.5

2.2

1.74

1.78

0.27

391

2665

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

410

2.20

10.86

2.2

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

334

2279

1.51

10.85

3.1

2.1

69.88

70.23

e9/l

0.05

245

1656

(3012501) Base excess in Blood by calculation

105

520

2.05

10.64

4.7

3.8

2.32

2.49

mmol/l

0.20

337

(40768806) Pleura Pathology biopsy report

145

3.06

10.61

1.4

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

296

1979

1.54

10.56

1.8

1.6

—

(3025159) Blasts/Leukocytes in Blood

364

2542

1.48

10.55

4.7

4.5

0.14

0.01

2.16

421

(3000060) B lymphocytes [#/volume] in Blood

4.24

10.55

3.2

1.9

0.27

0.17

e9/l

0.53

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

755

5973

1.33

10.52

4.2

3.8

130.55

421.81

ng/l

4.75

565

4450

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

5.43

10.39

1.5

1.1

20.94

1.75

umol/24h

0.52

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.41

10.25

2.8

1.6

—

0.64

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

124

662

1.90

10.16

2.0

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1091

9115

1.28

10.08

3.5

3.2

0.07

0.22

estimate

0.51

377

2673

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

139

772

1.83

10.07

3.7

1.4

5.13

1.52

ratio

0.70

436

(3045788) Cell count panel - Pleural fluid

183

2.76

10.02

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

267

1767

1.55

9.98

2.4

1.6

1.26

1.25

g/l

0.03

247

1638

(3009261) Glucose [Presence] in Urine by Test strip

1933

17288

1.25

9.98

4.2

3.9

0.01

estimate

0.07

441

3234

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

178

2.78

9.96

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

133

732

1.85

9.93

2.6

4.0

0.32

0.37

iu/ml

0.91

411

(3042631) Mycobacterium sp identified in Specimen

297

2.35

9.91

3.3

3.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3430

33192

1.64

9.89

28.6

16.8

75.95

74.05

umol/l

2.27

3412

32786

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

186

1130

1.68

9.87

2.3

2.0

7936.00

5691.37

u/l

0.26

464

(3006245) CD3-CD19+ cells/cells in Blood

3.63

9.80

3.1

2.0

13.77

10.51

0.57

(3027273) Bicarbonate [Moles/volume] in Venous blood

208

1307

1.63

9.69

3.3

3.1

25.93

25.46

mmol/l

1.09

198

1257

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

135

755

1.82

9.58

3.4

2.6

3.48

3.56

g/l

0.26

126

709

(3023199) Leukocytes [#/volume] in Pleural fluid

218

2.55

9.44

1.4

1.5

2591.51

2316.63

e6/l

0.08

157

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

312

2.27

9.30

1.8

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

273

1845

1.52

9.28

4.9

3.2

127.35

130.96

g/l

1.83

261

1786

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

478

2.01

9.27

5.1

5.7

1012.31

445.23

iu/ml

0.43

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

146

2.90

9.27

3.7

2.1

238.06

216.10

e6/l

0.30

124

(3023323) Follitropin [Units/volume] in Serum or Plasma

268

1805

1.52

9.26

1.6

1.4

29.46

27.89

iu/l

0.31

222

1579

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

151

883

1.74

9.23

3.9

1.5

31.87

32.09

mg/l

0.03

126

739

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

147

2.88

9.16

3.7

2.1

494.00

440.97

e6/l

0.33

119

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2325

21334

1.25

9.15

3.6

3.2

44.79

41.30

u/l

1.40

2186

20050

(3034860) Kappa light chains.free [Mass/volume] in Serum

151

886

1.73

9.12

4.0

1.5

42.60

41.64

mg/l

0.09

126

746

(3007853) Bacteria identified in Skin by Aerobe culture

466

3494

1.38

9.10

1.7

1.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

188

2.63

9.00

1.4

1.5

35230.72

74143.05

e6/l

0.49

106

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

180

2.63

8.67

1.9

1.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

+∞

8.33

1.0

0.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

1880

16982

1.22

8.06

4.2

3.9

0.00

estimate

0.41

449

3338

(3052851) Hemolysis interference index of Serum or Plasma

132

777

1.73

7.93

3.4

3.1

1.65

1.68

index

0.02

386

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

748

6119

1.28

7.89

1.5

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

1898

17197

1.22

7.77

4.2

3.9

5.55

3.70

estimate

0.18

463

3441

(3008295) Osmolality of Serum or Plasma

318

2.13

7.70

1.6

283.50

278.10

mosm/kgh2o

1.07

241

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

208

1385

1.53

7.61

2.1

2.0

38.48

39.83

u/l

0.42

183

1229

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

381

2845

1.38

7.60

2.7

2.3

36.32

54.39

u/l

0.50

323

2368

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

108

610

1.79

7.50

1.6

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

101

560

1.83

7.45

1.6

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

274

1939

1.45

7.43

2.9

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

322

2353

1.40

7.31

3.5

3.2

170.26

184.06

ng/l

0.26

293

2142

(3049717) Cytology report of Urine Cyto stain

128

765

1.70

7.31

2.7

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

852

7137

1.25

7.30

2.0

1.8

1.11

1.04

mg/l

0.19

649

5449

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

312

2.10

7.28

1.2

77.22

56.82

u/l

0.96

272

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

132

2.74

7.27

1.9

1.3

—

(21494434) Karyotype in Bone marrow

116

2.86

7.20

1.2

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1171

10169

1.22

7.16

2.4

2.2

171.89

206.96

u/l

0.84

1129

9582

(3012441) Differential panel - Pleural fluid

181

2.45

7.08

1.6

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

253

1784

1.45

7.00

2.2

1.7

—

(40768441) Liver Pathology biopsy report

165

2.50

6.91

1.0

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

503

1.83

6.81

1.5

1.4

130.04

151.99

au/ml

0.79

155

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1330

11747

1.21

6.75

3.9

3.6

41.49

56.76

ng/l

0.67

910

7725

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

506

1.82

6.69

1.6

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

134

831

1.64

6.67

2.3

2.2

12.07

11.29

mg/l

0.45

124

771

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1451

12936

1.20

6.64

4.1

3.8

1.31

0.11

estimate

0.45

389

2732

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

139

2.61

6.61

1.9

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

145

2.57

6.60

1.9

1.3

—

(4281824) Cell count and differential, peritoneal fluid

188

2.36

6.54

1.1

—

(40768797) Stomach Pathology biopsy report

560

4526

1.28

6.41

1.3

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

363

1.95

6.39

6.0

6.8

11.76

12.07

mg/l

0.24

340

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1038

8989

1.22

6.37

3.1

3.2

1417.19

1163.73

ng/l

0.64

887

7678

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

139

883

1.60

6.30

2.6

2.3

96.74

94.50

0.63

133

851

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

3.84

6.25

1.6

1.3

133.93

87.59

ng/l

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

133

840

1.61

6.18

2.8

2.4

178.74

179.65

0.04

125

793

(3010503) CD19 cells [#/volume] in Blood

123

2.62

5.96

3.1

2.4

104.84

137.73

e6/l

0.79

118

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

106

2.75

5.94

2.8

2.5

40.94

48.56

1.49

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

331

1.95

5.92

1.6

1.2

2.38

2.96

ug/l

0.60

293

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

396

1.86

5.85

1.7

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

807

6865

1.23

5.84

1.7

1.4

2.33

2.37

g/l

0.20

529

4127

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

175

1192

1.49

5.82

2.0

1.6

1.62

1.57

g/l

0.22

151

1028

(3000012) Reticulocyte production index

313

1.97

5.78

2.3

1.6

1.00

0.88

0.58

183

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.04

5.64

1.3

1.2

413.53

268.51

pmol/l

0.45

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

519

1.73

5.64

1.4

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

421

3335

1.30

5.62

1.7

1.6

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

318

2423

1.34

5.59

3.4

2.3

64.64

68.48

ml/min/173m2

1.07

160

976

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

8.48

5.55

1.5

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

583

1.68

5.51

1.4

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

142

940

1.53

5.43

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.87

5.42

1.1

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

549

4515

1.25

5.40

1.8

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

155

2.34

5.32

1.2

1.3

153.84

156.88

mmol/24h

0.09

155

(40765096) Chromosome analysis panel by Banding

4.72

5.29

1.1

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

195

2.17

5.21

6.0

2.7

—

(21494814) CD8 cells/Lymphocytes in Specimen

2.89

5.18

1.7

2.2

34.43

24.24

2.64

(3017732) Neutrophils [#/volume] in Blood

495

4042

1.26

5.17

3.1

2.8

4.00

4.45

e9/l

1.93

446

3494

(3020876) Protein [Mass/time] in 24 hour Urine

298

1.93

5.15

3.4

2.0

0.77

1.52

g/24h

1.86

157

(3021387) Prolactin [Units/volume] in Serum or Plasma

164

1133

1.47

5.12

2.3

1.7

315.19

298.45

mu/l

0.27

153

1015

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

177

2.22

5.12

1.7

1.5

5.96

7.06

u/l

0.23

145

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

520

1.69

5.08

1.7

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

642

5410

1.23

5.03

2.0

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

927

8094

1.20

5.03

2.9

2.3

334.31

333.10

umol/l

0.14

826

7100

(3036489) Thrombin time

161

1114

1.47

5.00

2.4

2.0

21.08

20.53

0.63

144

964

(3015235) Bicarbonate [Moles/volume] in Capillary blood

146

995

1.49

4.90

3.3

3.1

25.11

24.91

mmol/l

0.27

146

979

(3023419) Bacteria identified in Sputum by Culture

376

1.80

4.88

3.2

2.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

319

2482

1.31

4.87

5.9

3.4

4.83

4.58

kpa

1.14

306

2418

(3015736) pH of Urine

1495

13645

1.16

4.65

3.7

3.4

6.21

6.24

0.64

843

7636

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

5.47

4.59

5.3

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

207

1525

1.38

4.56

5.2

3.1

0.63

0.61

0.52

207

1519

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

3.28

4.46

3.2

2.1

0.25

0.17

nmol/l

0.33

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

251

1913

1.34

4.45

4.5

4.1

5.13

5.18

kpa

0.44

245

1827

(3003181) Sodium [Moles/volume] in Urine

571

1.61

4.45

1.4

62.79

61.18

mmol/l

0.12

466

(3009343) pH of Capillary blood

243

1848

1.34

4.38

4.5

4.1

7.42

7.41

1.50

215

1531

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

220

1648

1.36

4.38

2.3

2.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

420

1.70

4.36

1.3

1.2

17.66

21.87

u/l

0.52

362

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

423

3460

1.25

4.35

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

7.52

4.35

1.7

1.1

—

(3017704) Immunofixation for Urine

144

2.23

4.33

1.5

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

277

2151

1.31

4.31

1.5

—

(3017354) Segmented neutrophils/Leukocytes in Blood

211

2.00

4.31

3.8

2.5

57.35

57.71

0.03

174

(3024980) IgG subclass 4 [Mass/volume] in Serum

561

1.60

4.28

1.9

1.6

0.78

g/l

0.01

436

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

311

3899

0.78

4.27

5.0

5.1

32.65

32.84

0.11

207

2620

(21494890) Protein electrophoresis panel - 24 hour Urine

219

1.98

4.25

1.9

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

303

2389

1.29

4.22

2.5

2.3

0.36

0.31

e6/l

0.15

285

2267

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

187

1379

1.38

4.12

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3367

32968

1.30

4.03

15.5

10.3

24.87

25.22

u/l

0.69

3299

31943

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.90

3.99

1.4

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1038

9309

1.16

3.93

4.3

4.1

0.00

estimate

0.23

408

3166

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

214

1625

1.34

3.92

4.3

4.0

2.46

1.80

mmol/l

2.11

174

1210

(3014051) Protein [Presence] in Urine by Test strip

1039

9321

1.16

3.91

3.2

2.9

0.21

0.04

0.57

224

(3004451) EKG impression Narrative

158

2.10

3.87

1.2

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

346

1.72

3.78

1.5

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

346

1.72

3.78

1.5

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

346

1.72

3.78

1.5

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

346

1.72

3.78

1.5

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

194

1.97

3.77

2.0

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

167

2.05

3.74

1.4

1.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

133

943

1.43

3.72

1.4

320.41

303.65

ug/g

0.41

538

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

775

6823

1.17

3.69

1.7

456.05

49032019.43

pmol/l

7.75

621

5731

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

592

1.53

3.66

1.4

1.3

286.68

257.61

u/ml

0.46

346

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.54

3.62

1.5

2.8

0.62

mmol/l

0.16

(3016750) Collection duration of Urine

143

2.11

3.58

1.7

2.2

502.19

504.19

min

0.05

111

(3021960) Folate [Moles/volume] in Serum or Plasma

1015

9145

1.15

3.55

1.7

21.08

20.70

nmol/l

0.16

890

7713

(3047189) Immunofixation for 24 hour Urine

2.48

3.46

2.6

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

159

2.02

3.44

1.6

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

583

5041

1.19

3.44

1.4

445.61

549.45

titre

0.90

114

1130

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

119

840

1.43

3.43

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

515

1.55

3.37

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

515

1.55

3.37

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

515

1.55

3.37

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

154

2.02

3.34

1.6

1.3

—

(4062490) Immunoglobulin typing, IgG

344

1.67

3.33

1.6

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

352

1.66

3.32

1.6

1.4

2.71

2.84

g/l

0.18

250

(3024139) IgG subclass 3 [Mass/volume] in Serum

352

1.66

3.32

1.6

1.4

0.34

0.37

g/l

0.30

249

(3027135) IgG subclass 1 [Mass/volume] in Serum

353

1.65

3.29

1.6

1.4

6.77

6.74

g/l

0.03

250

(3006184) Hemoglobin [Mass/volume] in Capillary blood

101

700

1.46

3.23

2.6

2.3

125.85

130.83

g/l

1.09

550

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

206

1605

1.30

3.20

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1525

14195

1.13

3.18

2.1

1.9

1.37

1.35

mmol/l

0.35

1281

12024

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

124

2.10

3.13

1.4

1.3

10.58

13.88

u/l

3.03

117

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

118

2.13

3.09

5.5

4.9

—

(3037121) Protein [Mass/volume] in Urine

130

953

1.38

3.06

4.7

3.2

186.41

336.58

mg/l

3.10

335

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

10.01

2.98

11.2

1.0

—

(3009508) Creatinine [Moles/volume] in Urine

1239

11437

1.13

2.90

3.5

7.21

7.28

mmol/l

0.23

1065

9731

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

1024

1.35

2.87

2.7

1.4

10.04

10.20

g/l

0.15

124

892

(40768443) Skin Pathology biopsy report

168

1294

1.31

2.87

1.3

1.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

6.67

2.86

1.0

1.1

1.40

1.34

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

103

735

1.41

2.86

1.4

1.3

31.22

28.96

e6/l

0.05

550

(40758292) HTLV I+II Ab panel - Serum

3.34

2.81

1.8

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

3.58

2.78

2.5

1.9

15.09

15.59

ml/dl

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

104

748

1.40

2.77

1.4

793.16

972.81

e6/l

0.14

592

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

1179

1.32

2.76

2.7

1.4

4.24

4.28

g/l

0.29

142

1053

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

1180

1.32

2.75

2.7

1.4

7.30

7.46

g/l

0.55

142

1054

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

1180

1.32

2.75

2.7

1.4

3.60

3.70

g/l

0.50

141

1055

(3024928) Oxygen saturation in Venous blood

103

741

1.40

2.74

7.9

3.6

65.70

62.42

0.79

723

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

301

1.64

2.74

2.6

2.4

31.49

37.24

iu/ml

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.43

2.70

2.9

1.2

—

(3007461) Platelets [#/volume] in Blood

3450

34038

1.29

2.69

33.9

20.2

258.85

255.73

e9/l

2.16

3405

33343

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

4.22

2.67

7.1

1.6

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3450

34043

1.29

2.64

33.6

20.2

90.28

90.93

16.57

3430

33681

(3008536) Aspergillus sp Ab [Presence] in Serum

3.15

2.64

3.3

1.2

—

(3035941) MCH [Entitic mass]

3450

34044

1.29

2.63

33.6

20.1

30.00

30.25

16.30

3430

33682

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3450

34046

1.28

2.61

34.5

20.6

40.27

40.95

1.91

3429

33669

(3026361) Erythrocytes [#/volume] in Blood

3450

34048

1.28

2.60

33.7

20.2

4.51

4.50

e12/l

0.39

3397

33225

(3010813) Leukocytes [#/volume] in Blood

3450

34050

1.28

2.58

33.8

20.3

6.58

6.63

e9/l

0.55

3399

33215

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.30

2.57

1.2

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

135

1028

1.33

2.54

2.5

2.3

339.64

855.13

ug/l

1.44

130

970

(3000963) Hemoglobin [Mass/volume] in Blood

3450

34057

1.28

2.52

34.0

20.4

134.27

135.46

g/l

5.65

3430

33697

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

114

848

1.36

2.51

2.5

1.4

0.03

0.01

g/l

0.36

771

(3003327) Ova and parasites identified in Stool by Light microscopy

155

1214

1.29

2.39

1.6

1.7

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

6.26

2.37

1.2

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

6.26

2.37

11.8

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1296

0.73

2.36

1.4

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

118

1.96

2.35

1.0

1.2

118.30

112.39

0.52

105

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

143

1112

1.30

2.34

2.7

1.4

2.79

2.88

g/l

0.63

131

987

(3045716) Anion gap in Serum or Plasma by calculation

307

1.57

2.32

3.3

2.8

11.17

10.56

mmol/l

0.58

302

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

138

1069

1.30

2.32

1.5

1.8

0.25

0.23

g/l

1.71

127

1008

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

222

1.67

2.30

2.5

—

(3000494) Fungus identified in Specimen by Culture

447

3912

1.16

2.30

1.7

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

487

1.45

2.29

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

695

6277

1.13

2.27

6.1

4.0

2.42

1.87

ug/l

2.07

622

5666

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

109

820

1.34

2.26

2.5

1.4

0.00

g/l

-0.00

725

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

270

1.60

2.25

2.2

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

513

4547

1.15

2.22

2.5

2.4

112.95

122.33

ug/g

0.39

412

3616

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

240

1.63

2.22

2.3

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

5.56

2.21

7.6

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.20

1.3

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.41

2.19

2.1

2.3

6.65

7.57

mmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

674

6089

1.13

2.19

1.4

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

296

1.56

2.19

1.2

1.3

1.86

1.73

u/ml

0.03

174

(3024891) Influenza virus A+B Ag [Presence] in Specimen

106

799

1.34

2.18

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

893

8212

1.12

2.14

1.4

1.3

1.74

1.67

u/ml

0.07

257

2265

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

197

1.68

2.12

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

339

1.51

2.11

1.3

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

307

1.54

2.11

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

139

1098

1.28

2.05

1.5

1.8

1.19

g/l

0.02

129

1031

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

112

861

1.31

2.03

1.3

1.2

29.73

44.72

u/ml

0.63

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

100

758

1.33

2.01

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.64

2.00

1.1

1.2

2.46

1.98

ug/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.75

1.93

3.5

2.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

317

1.49

1.85

1.2

1.0

—

(3044941) Cell count panel - Synovial fluid

605

1.35

1.82

1.4

—

(3019150) Specific gravity of Urine by Refractometry

837

7735

1.11

1.82

4.4

4.1

1.02

1.22

kg/l

0.50

574

5031

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

528

1.37

1.82

1.3

1.2

4.52

5.03

u/ml

0.12

230

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

254

1.54

1.81

3.9

4.2

—

(3045414) Leukocytes [Presence] in Urine

275

3185

0.85

1.80

2.1

2.0

0.00

0.01

estimate

1.06

669

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1533

14579

1.09

1.79

2.1

96.26

97.61

pmol/l

0.47

796

7363

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

538

1.36

1.79

1.3

1.2

4.29

3.08

u/ml

0.21

191

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

117

923

1.28

1.78

1.4

1.3

—

(3044007) Cell count panel - Peritoneal fluid

2.17

1.77

1.6

2.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

117

1.80

1.74

1.7

1.6

0.44

0.36

ug/l

0.35

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

556

5039

1.12

1.73

4.9

3.7

22.12

24.20

2.63

293

2224

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

178

1.63

1.72

1.3

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.67

1.72

1.7

1.5

—

(3025941) Bacteria identified in Stool by Culture

206

1736

1.20

1.72

1.3

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

126

1009

1.26

1.71

3.0

1.4

0.70

0.34

g/l

0.43

101

865

(3004775) Volume in Urine collected for unspecified duration

202

1.59

1.71

1.9

2.4

677.43

622.43

0.25

138

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

262

2257

1.17

1.70

1.3

67.73

49.71

au/ml

0.53

140

(3051611) Lipemic interference index of Serum or Plasma

251

1.52

1.68

5.3

3.4

12.09

14.21

index

0.74

129

(21494755) Public health laboratory ask at order entry panel

257

2970

0.86

1.66

1.4

—

(1002224) Polysomnography panel

193

1624

1.20

1.65

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

555

1.34

1.65

1.7

2.9

25.38

34.68

umol/l

4.44

509

(3013139) Helicobacter pylori Ag [Presence] in Stool

282

2456

1.16

1.61

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

215

1.54

1.56

1.6

1.5

9.64

6.08

u/l

0.34

186

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

114

1.76

1.56

3.2

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

114

1.76

1.56

3.2

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

114

1.76

1.56

3.2

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

114

1.76

1.56

3.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.28

1.55

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.28

1.55

1.4

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.28

1.55

1.4

1.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

772

1.28

1.55

2.6

1.4

0.00

g/l

-0.00

724

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.60

1.51

2.0

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.86

1.50

1.2

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

108

1.76

1.50

1.7

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

108

1.76

1.50

1.7

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1133

10709

1.08

1.48

3.6

3.5

64.78

38.90

mg/l

2.16

701

6583

(3020393) Adenovirus Ag [Presence] in Stool

2.44

1.47

1.6

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

122

995

1.23

1.45

1.4

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

409

3682

1.12

1.45

3.3

2.8

0.74

0.71

ug/l

0.34

281

2281

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

140

1.65

1.44

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.13

1.44

1.2

1.1

—

(3022475) Manganese [Moles/volume] in Blood

3.13

1.44

1.2

1.1

0.15

umol/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1146

10852

1.08

1.43

4.3

4.2

11.68

8.86

mg/mmol

0.56

684

6560

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2067

20016

1.08

1.41

3.3

3.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

118

1.70

1.41

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

221

1.50

1.40

1.3

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

111

900

1.24

1.40

1.1

1.94

6.65

eliau/ml

2.23

105

(3017509) Phencyclidine [Presence] in Urine

2.42

1.39

1.1

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

278

2450

1.15

1.38

2.4

16.84

22.65

au/ml

0.90

261

(3015171) Extractable nuclear Ab [Units/volume] in Serum

176

1497

1.18

1.38

1.3

2.11

0.92

u/ml

0.29

132

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

214

1.50

1.38

2.7

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

214

1.50

1.38

2.7

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

214

1.50

1.38

2.7

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

150

1.60

1.37

1.5

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

114

934

1.23

1.33

1.3

1.2

80.00

154.25

titre

0.67

(3050129) First trimester maternal screen panel - Serum or Plasma

863

0.77

1.31

1.5

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

185

1.52

1.29

1.0

1.1

1.24

1.11

u/l

0.34

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.78

1.28

1.0

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.78

1.28

2.0

3.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

130

1.62

1.26

10.4

7.0

56.08

63.83

mg/l

0.45

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

504

1.29

1.22

1.2

1.1

120.02

117.89

0.19

457

(3052592) Norovirus Ag [Presence] in Stool

2.04

1.22

1.4

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

140

1.57

1.20

1.2

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

101

1.69

1.19

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

566

0.74

1.16

1.7

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

110

1.64

1.15

1.2

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

178

1543

1.16

1.15

1.5

1.9

9.91

7.03

iu/ml

0.46

373

(3022621) pH of Urine by Test strip

299

2686

1.12

1.14

2.7

2.6

6.11

6.08

0.21

197

1792

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

134

1136

1.19

1.13

1.4

1.3

12.95

44.53

u/ml

1.79

(3005322) IgE [Units/volume] in Serum or Plasma

266

2375

1.13

1.12

1.3

103.55

196.55

u/ml

4.10

245

2213

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.34

1.12

1.6

2.3

1.14

0.83

u/field

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

521

1.27

1.10

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.38

1.09

7.8

3.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.19

1.08

1.3

2.0

4.57

4.94

ug/l

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

240

2689

0.88

1.07

1.6

1.7

3.41

3.50

mmol/l

0.62

162

1848

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

191

0.57

1.04

1.5

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.27

1.03

1.4

2.0

—

(3023410) Appearance of Cerebral spinal fluid

332

1.33

1.03

1.5

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

560

5222

1.09

1.03

1.8

1.7

1171.98

1160.03

nmol/l

0.11

444

4013

(3034092) Cytoplasmic Ig cells/cells in Blood

2.06

1.02

4.9

9.4

0.13

0.18

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

655

1.23

1.00

1.8

2.1

0.91

0.82

nmol/l

0.57

556

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.00

1.00

1.1

1.3

6.20

5.95

mmol/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3094

30562

1.09

0.99

5.4

5.1

5.90

5.88

mmol/l

0.35

2903

28333

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

134

1154

1.17

0.98

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

112

1314

0.85

0.97

1.5

1.6

1024.39

1026.58

mu/l

0.01

1083

(3017569) Oxygen content in Arterial blood

149

1.48

0.95

1.8

1.9

14.72

16.56

1.86

149

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

117

1.54

0.93

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

670

1.21

0.93

2.7

2.3

166.94

96.64

ug/min

0.53

401

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

243

1.36

0.92

1.7

2.1

1.59

1.82

u/field

0.10

136

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2951

29887

0.93

0.92

4.3

1.31

1.27

mmol/l

2.36

2744

27741

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.14

0.91

2.7

3.1

55.17

43.89

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

2.14

0.91

5.3

6.3

8.83

7.82

—

(36660697) Celiac disease serology panel - Serum

321

2939

1.10

0.90

1.2

—

(4146454) Self-monitoring of blood glucose

337

0.71

0.90

2.1

2.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

168

1.43

0.89

1.3

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

245

1.35

0.89

3.0

2.7

19.50

29.26

mg/l

1.33

172

(3013637) Mi-2 Ab [Presence] in Serum

104

0.48

0.89

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

104

0.48

0.89

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

104

0.48

0.89

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

104

0.48

0.89

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.91

0.88

1.9

1.1

—

(3022313) Gas panel - Capillary blood

151

1325

1.15

0.88

4.7

4.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.61

0.87

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.58

0.87

1.3

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

144

1.46

0.87

4.0

2.5

24.17

74.47

ug/l

0.47

134

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

122

1055

1.16

0.87

1.4

1.3

4.71

6.63

u/ml

0.36

146

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

748

0.81

0.86

1.4

1.5

62.31

59.31

ug/l

0.16

609

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3099

31316

0.93

0.86

5.2

5.1

1.47

1.51

mmol/l

6.88

2913

29365

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.85

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.94

0.84

1.2

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

121

1051

1.16

0.82

1.4

1.3

1.72

5.90

u/ml

0.64

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

146

1.44

0.82

1.3

1.2

10.90

8.78

mm/h

0.34

146

(3000330) Specific gravity of Urine by Test strip

141

1599

0.88

0.81

3.2

1.02

ratio

0.88

129

1440

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

355

1.27

0.81

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

105

905

1.17

0.80

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.82

0.79

24.5

10.3

4.98

5.66

mmol/l

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

199

0.65

0.78

34.1

18.9

1162.92

1410.93

nmol/l

1.08

193

(3024471) HLA-A [Type]

1.62

0.78

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

127

1113

1.15

0.78

1.7

1.5

0.37

0.16

iu/ml

0.26

197

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.0

—

4.40

—

(40768446) Kidney Pathology biopsy report

115

1.48

0.76

1.6

1.8

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.08

0.74

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.67

0.74

1.2

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.00

0.72

1.2

17.20

19.20

u/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.67

0.72

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

480

1.21

0.71

1.7

1.4

32.11

27.72

u/l

0.38

373

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

344

0.75

0.71

1.2

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

471

1.21

0.71

1.1

1.98

2.94

eliau/ml

0.62

207

(4268621) Lupus anticoagulant assay

381

1.24

0.70

2.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

372

1.24

0.70

1.7

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3119

31467

0.94

0.69

5.3

5.2

4.67

4.72

mmol/l

1.88

2952

29701

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

193

0.67

0.69

22.2

14.0

704.23

7476.64

nmol/l

0.51

187

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

338

3625

0.93

0.69

1.9

2.0

3.47

3.41

ratio

0.47

263

2768

(3014891) Appearance of Pleural fluid

1.85

0.68

1.0

1.5

—

(3001556) Androgen free Index in Serum or Plasma

1.85

0.68

1.8

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

117

1033

1.14

0.67

2.6

1.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

215

0.70

0.67

1.1

0.27

1.54

u/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

113

1279

0.88

0.67

2.2

1.8

4.04

4.37

mg/l

0.14

943

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

530

1.19

0.66

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.79

0.66

8.0

3.0

22.60

23.34

mg/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

232

1.30

0.66

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

341

3646

0.93

0.65

1.6

1.7

1.40

1.44

0.58

295

3244

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.57

0.65

2.1

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

233

1.29

0.64

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

234

1.28

0.62

1.3

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.52

0.62

4.5

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.52

0.62

4.5

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.55

0.62

1.5

1.3

—

0.39

—

(3006576) Bicarbonate [Moles/volume] in Blood

1.48

0.60

10.2

6.5

25.57

25.08

mmol/l

0.21

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.60

0.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.50

0.59

4.5

1.1

—

(4195642) Thrombophilia screening test

500

1.18

0.59

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

2.7

—

3.10

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

639

0.84

0.59

1.5

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

487

0.82

0.59

1.6

1.5

69.12

57.80

ug/l

0.86

487

(3024932) HLA-DR beta [Type]

1.53

0.59

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

210

1.29

0.58

1.6

76.48

79.04

umol/l

0.17

210

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2695

26633

1.05

0.58

28.3

17.1

331.81

331.99

g/l

0.49

2686

26499

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

373

1.21

0.57

2.0

1.7

311.03

327.22

mu/l

0.26

294

(3045424) Erythrocytes [Presence] in Urine

141

1556

0.90

0.57

2.1

2.0

0.00

0.47

estimate

0.51

541

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

107

953

1.13

0.56

2.2

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

101

897

1.13

0.56

1.1

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.58

0.56

1.2

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.57

0.56

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.56

1.2

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

160

0.69

0.55

1.2

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

366

1.20

0.55

1.7

1.3

—

(3048879) Bone marrow aspiration report

1.58

0.54

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

367

1.20

0.54

1.7

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

160

1.31

0.53

1.2

1.4

143.09

216.90

pmol/l

0.65

160

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.53

2.7

2.9

5.09

4.93

kpa

0.18

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.53

2.7

2.9

10.15

10.26

kpa

0.05

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

295

1.22

0.52

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

591

1.15

0.52

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

117

1055

1.11

0.52

1.4

1.3

234.04

229.85

miu/ml

0.04

522

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

315

0.79

0.52

1.8

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

592

1.15

0.51

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

101

905

1.12

0.50

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.49

0.49

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.49

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

200

1857

1.08

0.49

1.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

323

0.80

0.48

1.2

1.4

1.59

1.43

nmol/l

0.28

289

(3017315) Amylase [Enzymatic activity/volume] in Urine

154

1.30

0.48

1.1

1.2

190.10

308.68

u/l

0.81

135

(3000475) Leukocytes [#/volume] in Synovial fluid

851

1.12

0.48

1.6

16410.35

10118.74

e6/l

0.66

599

(3003129) Base excess in Capillary blood by calculation

343

0.81

0.46

2.5

2.1

0.81

0.83

mmol/l

0.01

328

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.46

0.46

3.3

2.6

—

(3025130) Human papilloma virus identified in Specimen

570

1.14

0.46

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

821

7958

1.04

0.46

4.2

3.8

0.55

0.15

0.52

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.43

0.46

5.9

7.9

11.63

10.38

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3167

31867

0.95

0.46

6.1

5.9

2.74

2.76

mmol/l

0.82

2982

29972

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

103

1.36

0.45

1.9

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

103

1.36

0.45

1.9

1.3

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

460

1.15

0.44

2.5

2.6

13.42

13.18

0.62

455

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

197

0.76

0.44

1.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3020

29980

1.04

0.44

6.7

6.4

39.04

39.06

mmol/mol

0.06

2857

28228

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

157

1.28

0.43

1.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.61

0.43

1.0

1.7

31.80

49.32

umol/l

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

446

0.85

0.42

1.4

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

595

1.13

0.41

1.0

1.1

0.71

1.73

u/ml

1.28

296

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

890

1.10

0.41

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.41

0.0

1.1

—

172.88

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.36

0.41

1.8

3.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

224

2108

1.07

0.41

2.0

1.9

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.40

0.0

7.2

—

105.59

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.40

0.0

1.1

—

1.34

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.4

—

554.40

—

(3019174) dRVVT (LA screen)

1.47

0.40

1.2

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

399

1.15

0.39

1.8

1.6

68.52

57.82

1.12

239

(3010144) Erythrocytes [#/volume] in Synovial fluid

314

0.83

0.39

1.5

1.4

186428.20

89265.78

e6/l

0.29

209

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

160

0.75

0.39

1.6

6.2

—

52.81

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

104

0.67

0.39

1.1

1.6

7.26

9.25

ug/l

—

104

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.39

0.0

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

296

3110

0.95

0.38

2.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

107

1.31

0.37

1.4

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

318

1.17

0.36

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

488

1.13

0.36

1.1

1.02

2.61

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.40

0.35

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.36

0.34

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

200

1.20

0.33

1.3

1.1

1.06

1.05

ratio

0.04

164

(3014271) Vancomycin [Susceptibility]

127

1.26

0.33

2.6

2.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

221

0.81

0.33

1.2

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

466

0.88

0.32

1.0

1.1

0.11

0.25

u/ml

—

156

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

331

3447

0.96

0.32

2.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

341

1.15

0.32

1.8

1.3

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

295

1.15

0.31

1.8

1.5

30.09

34.66

0.30

176

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

219

0.82

0.31

1.3

1.4

—

508.10

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

185

1752

1.06

0.30

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

379

0.87

0.30

1.3

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

343

1.14

0.30

1.8

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

296

1.15

0.30

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

147

1383

1.07

0.30

1.3

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

144

1354

1.07

0.30

1.7

1.6

17.12

16.04

u/ml

0.07

318

(3038026) Centromere Ab [Units/volume] in Serum

268

1.16

0.30

1.3

1.2

45.52

58.04

u/ml

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

111

1.26

0.30

1.0

0.27

1.22

u/ml

0.63

111

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

1.28

0.30

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

102

1.28

0.30

1.2

1.1

94.71

93.00

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

682

0.91

0.29

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

114

1064

1.07

0.29

5.4

4.4

25.50

24.83

mmol/l

1.63

109

975

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

515

1.11

0.29

1.1

33.24

21667.80

iu/ml

0.53

108

(40759836) Histone Ab [Presence] in Serum by Immunoblot

317

1.14

0.28

1.2

—

(44813793) Dust mix specific IgE antibody measurement

248

0.85

0.28

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

153

1617

0.94

0.28

1.4

—

(3000492) Spirometry study

333

3212

1.04

0.27

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

346

1.13

0.27

1.7

2.3

33.60

21.88

mg/l

0.67

118

(3005988) Vibrio sp identified in Specimen by Organism specific culture

346

1.13

0.27

1.8

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

357

3694

0.96

0.27

7.7

6.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.25

0.27

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.25

0.27

2.0

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

181

1722

1.05

0.27

1.1

148.00

137.21

titre

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.21

0.26

1.1

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

592

0.91

0.25

1.1

29.89

18.63

au/ml

0.29

134

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.23

0.25

1.3

1.5

1.19

1.18

mmol/l

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

105

1.24

0.24

1.2

1.1

91.71

91.31

—

(3020650) Glucose [Presence] in Urine

105

1.24

0.24

2.1

1.8

0.00

0.09

estimate

1.08

105

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

870

1.07

0.24

1.3

12.31

3.35

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

223

0.85

0.24

1.0

1.1

1.09

2.01

u/ml

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.74

0.24

1.2

1.1

—

(3033099) Centromere Ab [Titer] in Serum

0.72

0.24

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

286

0.87

0.23

4.0

2.9

240.21

20.11

mg/l

0.57

201

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

246

1.14

0.23

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

147

0.82

0.23

1.5

1.4

—

1075418.09

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

692

0.92

0.23

1.4

1.5

1.10

1.20

ratio

0.35

415

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

692

0.92

0.23

1.4

1.5

1.40

1.13

ratio

0.82

413

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

692

0.92

0.23

1.4

1.5

0.92

0.96

ratio

0.24

413

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

211

0.85

0.23

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

681

6947

0.98

0.22

1.4

1.3

35.71

29.68

iu/ml

0.38

209

2107

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.22

1.0

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

116

1.21

0.22

1.0

1.3

78.32

136.76

nmol/l

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

191

1.15

0.21

1.4

1.2

0.56

0.57

ratio

—

117

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

430

1.09

0.21

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

662

1.07

0.21

3.5

4.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

315

1.11

0.21

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

315

1.11

0.21

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

6.08

—

(3018333) Ribosomal P Ab [Presence] in Serum

287

1.12

0.20

1.2

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.09

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

24.44

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

500

1.08

0.19

1.2

—

(3042733) HLA Ab [Presence] in Serum

1.21

0.19

5.0

4.7

—

(3008898) HLA-B27 [Presence]

133

1271

1.05

0.19

1.1

—

(40757373) Influenza virus identified in Isolate

1.15

0.19

1.0

1.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

337

1.10

0.19

1.5

1.8

—

1648.00

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

569

1.07

0.19

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

367

1.09

0.18

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

107

1020

1.05

0.17

1.4

1.3

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1.10

0.17

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

142

0.84

0.17

1.7

2.3

56.40

163.22

umol/l

—

(3011288) Drugs identified in Urine by Screen method Nominal

794

0.94

0.17

2.3

2.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.73

0.17

1.6

2.0

20.36

16.77

umol/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

152

0.85

0.16

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.11

0.16

1.1

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

266

0.90

0.15

1.3

1.2

572.00

205.87

titre

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.75

0.15

1.0

32.70

35.55

iu/ml

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.21

0.15

1.0

1.1

115.54

50.47

u/ml

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

595

0.94

0.15

1.5

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

492

0.93

0.15

1.0

1.1

0.56

4.39

u/ml

5.88

212

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.78

0.14

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

150

1.13

0.14

1.4

1.7

7.69

8.42

mmol/l

0.44

150

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

304

1.09

0.14

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

181

0.88

0.14

1.2

1.1

1943.25

1531.87

miu/ml

0.70

181

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

227

1.10

0.14

1.1

17.86

16.27

u/ml

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

577

1.06

0.14

3.5

3.4

0.82

0.83

nmol/l

0.12

473

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

264

0.91

0.14

1.0

1.1

19.03

8.31

iu/ml

—

(4034850) Laboratory test

102

1062

0.96

0.14

12.8

9.1

—

(3020491) Glucose [Moles/volume] in Blood

222

0.90

0.13

2.5

2.4

8.35

6.54

mmol/l

1.00

143

(44806420) Estimation of glomerular filtration rate

383

1.07

0.13

2.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

257

1.09

0.13

1.5

1.6

0.85

1.20

promille

0.59

201

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

248

2538

0.98

0.13

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

106

0.85

0.13

1.1

1.3

16.22

17.47

umol/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

108

0.83

0.13

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

109

0.83

0.13

1.1

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

903

1.04

0.13

1.2

4.58

3.79

0.26

117

(3005033) Fetal Nuchal fold Thickness US

570

0.95

0.12

1.4

1.5

1.21

1.28

0.54

397

(4198724) Urine methamphetamine measurement

114

1.14

0.11

2.5

1.9

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

405

0.94

0.11

1.6

2.1

5.09

5.95

umol/l

0.22

288

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

544

1.05

0.10

1.9

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.14

0.10

1.4

2.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.11

0.09

1.0

1.1

12.10

6.84

u/ml

—

(3004616) Nuclear Ab [Presence] in Serum

463

0.95

0.09

1.5

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

174

1.09

0.09

1.2

1.3

123.37

133.79

nmol/l

1.17

174

(3045683) HLA typing for celiac disease panel - Blood or Tissue

217

0.92

0.09

1.1

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

186

0.91

0.09

1.1

0.24

2.27

u/ml

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

175

1.09

0.08

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

130

1331

0.98

0.08

1.8

1.5

0.31

0.32

mg/l

0.12

584

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

277

0.94

0.08

1.3

1.4

8.02

8.43

mmol/l

0.21

268

(3034426) Prothrombin time (PT)

117

1.11

0.08

1.2

27.92

28.69

0.17

117

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.03

0.07

5.9

7.6

4.93

4.98

kpa

—

(3044927) Protein electrophoresis panel - Urine

313

1.05

0.07

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

581

0.96

0.07

1.4

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

264

1.06

0.07

1.2

39.77

35.53

mg/l

0.14

224

(4094501) Cardiovascular stress test using bicycle ergometer

945

0.97

0.07

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

137

1.10

0.07

1.7

2.4

—

(3002619) Bacteria identified in Specimen by Culture

0.87

0.07

1.0

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.07

0.07

2.0

1.5

0.50

0.48

e9/l

—

(4211845) Urine protein measurement

157

1.08

0.07

2.0

3.2

—

(3028433) Virus identified in Specimen by Culture

1.05

0.07

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

769

1.03

0.06

1.0

1.1

1.20

2.06

u/ml

0.98

413

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

463

1.04

0.06

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

112

1142

0.98

0.06

1.1

0.59

0.65

ratio

0.58

146

(3028300) Cannabinoids [Presence] in Urine

112

1140

0.98

0.05

1.8

1.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

535

0.97

0.05

1.0

1.1

1.22

3.45

u/ml

2.43

262

(3028707) Methadone [Presence] in Urine by Screen method

493

0.97

0.04

2.3

2.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

428

1.03

0.03

1.7

1.9

—

7.50

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

653

0.98

0.03

2.9

3.5

34.89

25.00

mg/l

0.81

455

(1761868) Lipid panel - Serum or Plasma

1268

12705

1.00

0.02

3.3

3.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

138

0.94

0.02

1.2

—

(3027008) Opiates [Presence] in Urine

112

1132

0.99

0.02

1.8

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

287

2885

0.99

0.02

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

107

0.93

0.02

2.8

2.7

33.26

29.12

umol/l

—

(3022689) Creatine [Moles/volume] in Urine

117

0.94

0.01

1.3

1.4

5.40

7.92

mmol/l

1.89

117

(3006462) Nitrate [Presence] in Urine

143

1.05

0.01

2.1

3.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

650

6513

1.00

0.01

1.4

1.3

11.21

11.89

u/ml

0.09

250

2609

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

122

1229

0.99

0.01

1.2

1.1

1.52

1.55

g/l

0.59

122

1229

(3008401) Mugwort IgE Ab [Units/volume] in Serum

637

0.99

0.01

1.0

1.1

0.59

0.96

u/ml

0.43

278

(4024509) Urine culture

159

1597

1.00

0.00

1.8

1.9

—

(3027944) Amphetamines [Presence] in Urine

113

1124

1.01

0.00

1.8

1.9

—

(3024263) Appearance of Synovial fluid

162

0.99

0.00

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

248

1.01

0.00

1.0

901.17

726.49

ng/l

0.68

161

(1001926) Buprenorphine [Presence] in Urine by Screen method

895

1.01

0.00

2.0

1.9

—

(3016879) Cocaine [Presence] in Urine

105

1045

1.00

0.00

1.7

2.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

149

1.01

0.00

1.2

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

251

1.00

0.00

1.0

32.95

46.66

ng/l

1.04

167

(3006270) Folate [Moles/volume] in Blood

261

1.00

0.00

1.2

1.1

347.76

390.69

nmol/l

0.50

232

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

261

1.00

0.00

1.3

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

611

1.00

0.00

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

654

0.99

0.00

1.1

3.45

4.34

u/ml

0.42

350

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

126

1.03

0.00

1.3

1.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

246

1.02

0.00

1.0

283.58

347.65

ng/l

0.80

167

(3025018) Bordetella pertussis Ab [Titer] in Serum

244

0.98

0.00

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

113

1129

1.00

0.00

1.7

1.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

251

2509

1.00

0.00

2.2

2.4

5.76

7.31

ug/l

0.66

217

2209

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

113

0.97

0.00

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

213

0.99

0.00

1.2

—

(4015189) Microbial culture of sputum

0.95

0.00

4.4

2.8

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

4.7

—

(3032057) Clostridioides difficile [Presence] in Stool

0.88

0.00

1.8

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.86

0.00

6.0

6.8

9.28

7.97

mmol/l

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

153.20

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1228.00

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

27.69

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.8

—

0.24

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.95

0.00

5.4

7.4

5.97

6.03

kpa

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.2

—

4.51

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

9.0

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

3.40

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2767.67

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

305.00

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.02

-0.00

1.0

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.00

-0.00

1.1

1.2

0.01

1.16

u/ml

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

471.00

—

(3033086) Enterovirus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_ENDOCRINE_WIDE – Malignant neoplasm of endocrine gland, including Hilmo

GWS hits: 18

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of endocrine gland, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints